0000813623 false N-CSRS 0000813623 2023-01-01 2023-06-30 0000813623 swz:CommonSharesMember 2023-06-30 0000813623 swz:CommonSharesMember 2023-06-30 2023-06-30 0000813623 swz:CommonSharesMember 2022-12-31 0000813623 swz:CommonSharesMember 2021-12-31 0000813623 swz:CommonSharesMember 2020-12-31 0000813623 swz:CommonSharesMember 2019-12-31 0000813623 swz:CommonSharesMember 2018-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES



811-05128
Investment Company Act file number



The Swiss Helvetia Fund, Inc.
(Exact name of registrant as specified in charter)


c/o U.S. Bank Global Fund Services
615 East Michigan Street
Milwaukee, WI  53202
(Address of principal executive offices) (Zip code)


Andrew Dakos, President and Chief Executive Officer
 c/o U.S. Bank Global Fund Services
615 East Michigan Street
Milwaukee, WI  53202
(Name and address of agent for service)



 1-800-730-2932
Registrant's telephone number, including area code



Date of fiscal year end: December 31, 2023



Date of reporting period:  June 30, 2023





Item 1. Reports to Stockholders.

(a)



 
The Swiss Helvetia Fund, Inc.
Executive Offices
615 East Michigan Street
Milwaukee, WI 53202
(800) 730-2932
 



A Swiss Investments Fund
Semi-Annual Report
www.swzfund.com
 
 
For the Six Months Ended
 
June 30, 2023



THE SWISS HELVETIA FUND, INC.



Managed Distribution Policy Disclosure
 
In May 2018, The Swiss Helvetia Fund, Inc. (the “Fund”), acting pursuant to an SEC exemptive order and with the approval of the Fund’s Board of Directors (the “Board”), adopted a managed distribution policy. Under that policy, as resumed by the Board and as currently in effect, the Fund will pay a quarterly distribution stated in terms of a fixed amount of $0.12285 per share of the Fund’s common stock, which equates to an annualized distribution rate of 6.00% based on the Fund’s net asset value of $8.19 as of October 31, 2022. In accordance with the policy, the Fund distributed on March 31, 2023 and June 30, 2023, $0.12285 per share to stockholders of record on March 22, 2023 and June 21, 2023, respectively.
 
You should not draw any conclusions about the Fund’s investment performance from the amount of the Fund’s distribution or from the terms of the Fund’s managed distribution policy. The Board reviews the Fund’s managed distribution policy periodically and may amend or terminate the managed distribution policy at any time without prior notice to Fund stockholders, which could have an adverse effect on the market price of the Fund’s shares.
 
With each distribution, the Fund will issue a notice to stockholders and a press release which will provide detailed information regarding the amount and composition of the distribution and other related information. The amounts and sources of distributions reported in the notice to stockholders are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099- DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. Please refer to “Federal Income Tax and Investment Transactions” under Note 5 of the Notes to Financial Statements for information  regarding the tax character of the Fund’s distributions. A copy of the Fund’s Section 19(a) notices is available on the Fund’s website at www.swzfund.com.
 
The Fund’s total return in relation to changes in net asset value is presented in the Financial Highlights.
 


1

THE SWISS HELVETIA FUND, INC.



Management Discussion and Analysis (as of June 30, 2023)
 
For the six-month period ended June 30, 2023, The Swiss Helvetia Fund, Inc. (the “Fund”), as measured by the change in the Fund’s net asset value (“NAV”), increased by +13.2% in US dollars (“USD”) on a total return basis. For the same period, the Fund’s closing share price on the New York Stock Exchange increased by +12.2% in USD on a total return basis. This compares with an increase of 11.5% in the Swiss Performance Index (the “Index” or the “SPI”) in USD.
 
Economic environment during the period under review
 
Global economic review
For the year 2023, the global economy was expected to recover mainly due to re-opening in China after the end of strict COVID-19 restrictions. However, in the first half of the year, the anticipated recovery in China disappointed, while Western economies stayed stronger than anticipated.
 
Major central banks further raised interest rates to fight inflation. The Federal Reserve (“Fed”) raised interest rates ten times in a row since spring 2022. In June 2023, for the first time, the Fed elected to keep the rate steady. The key interest rate in the US remains in a range of 5.00% to 5.25%, the highest level since 2007. The US has so far avoided recession despite most early warning signs flashing red. Robust labor market conditions and expansive fiscal policy are helping to sustain growth, while core inflation (year over year) remained elevated at 4.4% in June.
 
The European Central Bank (“ECB”) not only raised interest rates in the eurozone to 4.0%, representing the ninth tightening since last summer and the highest rate since the beginning of 2008, but it even held out the prospect of further increases. Core inflation (year over year) in Europe crept up to 5.4% in June from 5.3% in May. Growth data showed that the eurozone experienced a mild recession over the winter, with GDP declines of -0.1% in both fourth quarter of 2022 and first quarter of 2023. Forward-looking data pointed to slowing momentum in the eurozone economy.
 
Market environment
Global equities gained during the first half of 2023, led by developed markets, notably the US, and buoyed by receding recession worries in these markets. Gains came despite the collapse of Silicon Valley Bank, which caused significant volatility in bank shares, and as enthusiasm over Artificial Intelligence boosted technology stocks.
 
Worldwide equities, measured by the MSCI World Index, increased +15.4% in USD for the first half of 2023.
 
With respect to European equities during the first half of 2023, the MSCI
 


2

THE SWISS HELVETIA FUND, INC.



Europe Index increased +11.7% in EUR, and the strengthening of the EUR translated into a +13.8% USD increase.
 
Swiss equities, as measured by the SPI, increased by +8.2% in the first half of 2023 (in CHF, which translates to a +11.5% USD increase). Within Switzerland, small and mid-cap companies, represented by the SPI Extra Index (the “SPIEX”), increased by +10.0% and outperformed the large cap companies segment, represented by the Swiss Market Index Total Return (the “SMIC”), by +1.7%.
 
In fixed income, government bond yields fell (meaning prices rose) in the first quarter of 2023, followed by rising yields in the second quarter of the year.
 
All sectors within the SPI performed positively. Utilities showed the strongest performance in the first half of 2023 (+31.0%), followed by Consumer Discretionary (+26.2%), Industrials (+24.4%) and Materials (+21.2%).
 



IMPORTANT INFORMATION CONCERNING
MANAGEMENT DISCUSSION AND ANALYSIS

Except as otherwise specifically stated, all information and investment team commentary, including portfolio security positions, is as of June 30, 2023. The views expressed in the Management Discussion and Analysis section (the “MD&A”) are those of the Fund's portfolio manager and are subject to change without notice. They do not necessarily represent the views of Schroders Investment Management North America Inc. The MD&A contains some forward-looking statements providing current expectations or forecasts of future events; they do not necessarily relate to historical or current facts. There can be no guarantee that any forward-looking statement will be realized. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events, or otherwise. Any discussions of specific securities should not be considered a recommendation to buy or sell those securities. The Fund may buy, sell, or hold any security discussed herein, on the basis of factors described herein or the basis of other factors or other considerations. Fund holdings will change from time to time. Current and future portfolio holdings are subject to risk, including geopolitical and other risks.
 
Performance quoted represents past performance and does not guarantee or predict future results.

3

THE SWISS HELVETIA FUND, INC.



Swiss Performance Index for the first half of 2023



Source: Schroders, Blackrock Solutions / Aladdin Explore, as of June 30, 2023. Performance measured as total return in USD. Sectors mentioned should not be viewed as a recommendation to buy/sell. Portfolio composition is subject to change over time. Investors cannot invest directly in the Index or sub-indices.


Performance
 
The Fund’s NAV increased by +13.3% in USD, which outperformed the Index’s return for the period under review.
 
In terms of stock picking, overweights in Aryzta, Swissquote, BKW, SFS, SIG, Richemont and Software One, as well as underweights in Credit Suisse and Roche had a positive impact on relative performance.
 
The biggest detractors to relative performance came from overweights in Oerlikon, Tecan, Idorsia, Baloise and Logitech. Other detractors to performance came from underweights in Holcim, ABB, SGS, Straumann and Lindt & Spruengli.

4

THE SWISS HELVETIA FUND, INC.



The Fund’s private equity position Aravis Biotech received a distribution in excess of CHF 1.6 million from the sale of a portfolio company.
 
Portfolio changes
 
In total, there were 11 purchases and 18 sales of listed equities on a net basis in the first half of 2023. As of June 30, 2023, there were 43 listed companies held by the Fund and 4 direct private equity investments, including one participation in a private equity limited partnership.
 


New Investments by the Fund

Barry Callebaut
DKSH
Galenica


Additions to Existing Investments

Accelleron
Alcon
Baloise
Givaudan
Julius Baer
Kuehne & Nagel
Sonova
St. Galler KB


Positions Entirely Disposed of

Polypeptide


Reductions in Existing Investments

ABB
AMS
Aryzta
Comet
Geberit
Helvetia
Logitech
Nestlé
Partners Group
Cie Financiere Richemont
SIG Gombibloc
Sika
Software One
Swissquote
The Swatch
UBS
VAT Group


5

THE SWISS HELVETIA FUND, INC.



The Fund established new positions in Barry Callebaut, DKSH and Galenica.
 
Barry Callebaut is the world leading cocoa processing and chocolate production company. Barry Callebaut’s share price took a hit in 2022 as they had a production interruption in their biggest plant in Belgium due to contamination with salmonella. The problems appear to have been solved and production is up and running.
 
DKSH helps companies to grow their business in existing markets and expand into new ones. DKSH has its business activities mainly in Asia, a region benefitting from the end of the lock-down in China. The company has undertaken certain initiatives that we anticipate will improve margins.
 
Galenica is the leading fully integrated healthcare provider in Switzerland. We believe that Galenica has a resilient business and during the period it became relatively cheap for its earnings visibility.
 
When the financial sector sold-off during worries about Credit Suisse’s going concern, the Fund increased the weight in Baloise and Julius Baer. The Fund further increased Kuehne & Nagel, where it is expected that margins stay sustainably higher than before the Covid-crisis. The Fund also increased its position in Sonova, as the company remains attractively valued within the sector and compared to its own history.
 
The Fund sold its entire position in Polypeptide as the company did not appear able to cope adequately with an input cost rise and had production issues. Partial profits were taken in ABB, Comet, Richemont, SIG Combibloc, Swissquote and VAT Group. The Fund also reduced its positions in Geberit, Logitech, and UBS, where the Fund’s investment adviser sees a more complex future ahead. Additionally, the Fund reduced its holding in Software One after the company received a takeover bid.
 
Outlook
 
As central banks continue to raise interest rates, signs are appearing that the impact is starting to be felt. Manufacturing activity is trending downwards, especially in Europe and Asia. Meanwhile, services continue to rebound, probably as households continue to rebalance their spending patterns back to pre-pandemic norms. The new baseline forecast has global GDP growth slowing to 2.4% this year and to 1.9% in 2024. This represents an upward revision for this year, mostly driven by upgrades to the US forecast. US households have proven to be more resilient, which in turn has allowed companies to pass on more of their costs through prices increases, but has also allowed them to keep hiring, re-enforcing a robust labour market.
 

6

THE SWISS HELVETIA FUND, INC.




Source: Schroders Economics Group, 25 May 2023.
 
 
The forecasted US recession has been pushed out by a quarter, and the profile for the Fed funds forecast has been raised slightly. Inflation has started to fall, but has been stickier on the back of higher services inflation. The forecast for the eurozone has been revised up slightly as support from stronger export markets is expected to be partially offset by higher interest rates. European inflation has also proven to be more persistent, but is expected to fall back significantly by early 2024, allowing for rate cuts. China experienced a weaker than expected recovery after authorities loosened Covid-19 restrictions. Other emerging markets also saw economic activity soften as the pronounced tightening of monetary policies in the US and Europe started to affect these economies.
 
The investment adviser is convinced that a strong balance sheet will be important in either a recession or in an extended upturn as portfolio companies need to be able to stomach an interest rate burden that is much heavier than during or pre-Covid. Pricing power remains important, otherwise, the margin increase that some companies may achieve in the first half of 2023 will be transitory and their earnings may fall when they need to give back falling energy and other input costs or when competition forces them to do so. Accordingly, the investment adviser intends to keep a balanced portfolio with companies that are not expensively valued and which are strongly capitalised leaders in their field.
 

7

THE SWISS HELVETIA FUND, INC.






Performance at a glance (unaudited)
 
Average annual total returns for the Fund’s common stock for the periods ended 6/30/2023
 
Net asset value returns
1 year
5 years
10 years
The Swiss Helvetia Fund, Inc.
18.67%
8.43%
7.29%
       
Market price returns
     
The Swiss Helvetia Fund, Inc.
12.18%
6.98%
7.54%
       
Index returns
     
Swiss Performance Index
14.51%
9.78%
8.04%
       
Share price as of 6/30/2023
     
Net asset value
   
$9.70
Market price
   
$8.22

Past performance does not predict future performance. The return and value of an investment will fluctuate so that an investor’s share, when sold, may be worth more or less than their original cost. The Fund’s common stock net asset value (“NAV”) return assumes, for illustration only, that dividends and other distributions, if any, were reinvested at the NAV on the ex-dividend date. The Fund’s common stock market price returns assume that all dividends and other distributions, if any, were reinvested at the lower of the NAV or the closing market price on the ex-dividend date. NAV and market price returns for the period of less than one year have not been annualized. Returns do not reflect the deduction of taxes that a stockholder could pay on Fund dividends and other distributions, if any, or the sale of Fund shares.
 
The Swiss Performance Index (SPI) is considered Switzerland's overall stock market index. It comprises practically all of the SIX Swiss Exchange-traded equity securities of companies that are domiciled in Switzerland or the Principality of Liechtenstein. You cannot invest directly in an index.
 


8

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — 96.28%
           
             
Advertising — 0.48%
           
                       
 
8,100
 
DKSH Holding AG
 
$
602,532
     
0.48
%
     
An international
               
     
marketing and services
               
     
group. The company offers
               
     
a comprehensive package
               
     
of services that includes
               
     
organizing and running
               
     
the entire value chain
               
     
for any product.
               
     
(Cost $624,087)
               
           
602,532
     
0.48
%
Banks — 2.61%
               
                       
 
895
 
St Galler Kantonalbank AG
   
485,190
     
0.38
%
     
Offers retail and
               
     
commercial banking
               
     
as well as private and
               
     
institutional banking.
               
     
Also provides asset
               
     
management and financial
               
     
planning services.
               
     
(Cost $439,441)
               
                       
 
138,800
 
UBS Group AG
   
2,807,339
     
2.23
%
     
Provides retail banking,
               
     
corporate and institutional
               
     
banking, wealth
               
     
management, asset
               
     
management and
               
     
investment banking.
               
     
(Cost $1,884,953)
               
           
3,292,529
     
2.61
%
Biotechnology — 2.63%
               
                       
 
41,308
 
Idorsia Ltd.1
   
297,811
     
0.24
%
     
Researches, develops,
               
     
and manufactures
               
     
pharmaceutical, biological,
               
     
and diagnostic products.
               
     
(Cost $1,141,326)
               
                       
 
5,062
 
Lonza Group AG
   
3,018,019
     
2.39
%
     
Produces organic fine
               
     
chemicals, biocides,
               
     
active ingredients, and
               
     
biotechnology products.
               
     
(Cost $2,925,070)
               
           
3,315,830
     
2.63
%
Building Materials — 3.41%
               
                       
 
820
 
Forbo Holding AG
   
1,176,862
     
0.93
%
     
Produces floor coverings,
               
     
adhesives and belts for
               
     
conveying and power
               
     
transmission.
               
     
(Cost $1,292,481)
               
                       
 
1,097
 
Geberit AG
   
573,974
     
0.46
%
     
Manufactures and supplies
               
     
water supply pipes and
               
     
fittings, installation, and
               
     
drainage and flushing
               
     
systems such as visible
               
     
cisterns other sanitary
               
     
 systems for the
               
     
commercial and residential
               
     
construction markets.
               
     
(Cost $482,481)
               
                       
 
8,912
 
Sika AG
   
2,547,140
     
2.02
%
     
Manufactures construction
               
     
materials, producing
               
     
concrete and mixtures,
               
     
mortar, sealants and
               
     
adhesives, tooling resins,
               
     
anti-static industrial
               
     
flooring, and acoustic
               
     
materials. The company
               
     
serves customers
               
     
worldwide.
               
     
(Cost $1,731,659)
               
           
4,297,976
     
3.41
%



See Notes to Financial Statements.

9

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Chemicals — 1.50%
           
                       
 
570
 
Givaudan SA
 
$
1,889,063
     
1.50
%
     
Manufactures and markets
               
     
fragrances and flavors
               
     
from natural and synthetic
               
     
ingredients. The Company
               
     
sells its products to
               
     
manufactures of perfumes,
               
     
beverages, prepared foods,
               
     
and consumer goods.
               
     
(Cost $1,865,973)
               
           
1,889,063
     
1.50
%
Computers — 1.82%
               
                       
 
31,300
 
Logitech International SA
   
1,862,641
     
1.48
%
     
Engages in the development
               
     
and marketing of hardware
               
     
and software products that
               
     
enable or enhance digital
               
     
navigation, music and video
               
     
entertainment, gaming,
               
     
social networking and audio
               
     
and video communication.
               
     
(Cost $424,372)
               
                       
 
22,000
 
SoftwareONE Holding AG
   
435,992
     
0.34
%
     
Provides IT services. The
               
     
Company offers cloud
               
     
computing, portfolio
               
     
management, procurement,
               
     
unified communication,
               
     
and other related solutions.
               
     
(Cost $400,813)
               
           
2,298,633
     
1.82
%
Diversified Financial Services — 3.85%
               
                       
 
24,600
 
Julius Baer Group Ltd.
   
1,549,169
     
1.23
%
     
Provides private banking
               
     
services. The company
               
     
advises on wealth
               
     
management, financial
               
     
planning and investments;
               
     
offers mortgage and other
               
     
lending, foreign exchange,
               
     
securities trading, custody
               
     
and execution services.
               
     
(Cost $1,180,871)
               
                       
 
10,000
 
Swissquote Group
               
     
Holding SA
   
2,075,672
     
1.64
%
     
Through its subsidiaries,
               
     
offers online financial
               
     
services. The company
               
     
operates an online trading
               
     
system which offers
               
     
customers real-time
               
     
securities quotes on the
               
     
Swiss Stock Exchange.
               
     
(Cost $986,509)
               
                       
 
13,408
 
VZ Holding AG
   
1,231,920
     
0.98
%
     
Provides independent
               
     
financial advice to private
               
     
individuals and companies.
               
     
The company consults on
               
     
investment, tax and
               
     
inheritance planning and
               
     
provides advice regarding
               
     
insurance products and
               
     
coverage.
               
     
(Cost $438,472)
               
           
4,856,761
     
3.85
%



See Notes to Financial Statements.

10

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Electric — 2.06%
           
                       
 
14,700
 
BKW AG
 
$
2,596,099
     
2.06
%
     
Provides energy supply
               
     
services. The company
               
     
focuses on the production,
               
     
transportation, trading and
               
     
sale of energy. In addition
               
     
to energy supply, the
               
     
company also develops,
               
     
implements and operates
               
     
energy solutions
               
     
for its clients.
               
     
(Cost $1,177,241)
               
           
2,596,099
     
2.06
%
Electronic Components & Equipment — 2.15%
               
                       
 
43,024
 
ABB Ltd.
   
1,691,817
     
1.34
%
     
Provides power and
               
     
automation technologies.
               
     
The company operates
               
     
under segments that include
               
     
power products, power
               
     
systems, automation
               
     
products, process
               
     
automation, and robotics.
               
     
(Cost $872,256)
               
                       
 
3,967
 
Comet Holding AG
   
1,012,757
     
0.81
%
     
Develops, produces, and
               
     
distributes components
               
     
and systems for x-ray tubes,
               
     
vacuum condensers, and
               
     
radio frequency, as well as
               
     
other medical products.
               
     
(Cost $1,012,150)
               
           
2,704,574
     
2.15
%
Food — 21.40%
               
                       
 
1,480,000
 
Aryzta AG1
   
2,454,949
     
1.95
%
     
Produces and retails
               
     
specialty bakery products.
               
     
The Company produces
               
     
French breads, pastries,
               
     
continental breads,
               
     
confections, artisan breads,
               
     
homestyle lunches,
               
     
viennoiserie, patisserie,
               
     
cookies, pizza, appetizers,
               
     
and sweet baked goods.
               
     
(Cost $1,589,760)
               
                       
 
630
 
Barry Callebaut AG
   
1,216,129
     
0.96
%
     
Manufactures cocoa
               
     
and chocolate products.
               
     
The Company markets
               
     
to industrial food
               
     
manufacturers, chocolatiers,
               
     
pastry chefs, bakers, and
               
     
retailers globally.
               
     
(Cost $1,230,486)
               
                       
 
193,837
 
Nestle SA
   
23,312,872
     
18.49
%
     
One of the world’s largest
               
     
food and beverage
               
     
processing companies.
               
     
(Cost $12,557,687)
               
           
26,983,950
     
21.40
%
Healthcare-Products — 6.07%
               
                       
 
26,357
 
Alcon, Inc.
   
2,183,037
     
1.73
%
     
Manufactures eye care
               
     
products. The company
               
     
produces and markets
               
     
vitreoretinal and cataract
               
     
surgery, contact lenses,
               
     
and refractive technology
               
     
products.
               
     
(Cost $1,752,716)
               



See Notes to Financial Statements.

11

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Healthcare-Products — (continued)
           
                       
 
125,416
 
Eyesense AG, Series A1,2,3
 
$
50,466
     
0.04
%
     
A spin-out from Ciba
               
     
Vision AG. Develops novel
               
     
ophthalmic self- diagnostic
               
     
systems for glucose
               
     
monitoring of diabetes
               
     
patients.
               
     
(Cost $3,007,048)
               
                       
 
5,990
 
Medacta Group SA
   
815,494
     
0.65
%
     
Produces and distributes
               
     
medical devices. The
               
     
company develops,
               
     
manufactures, and
               
     
distributes orthopedic
               
     
and neurosurgical
               
     
medical devices.
               
     
(Cost $627,328)
               
                       
 
6,848
 
SKAN Group AG
   
589,388
     
0.47
%
     
Provides health care
               
     
supplies. The Company
               
     
offers isolators, cleanroom
               
     
devices, and decontamination
               
     
processes for the aseptic
               
     
production of the
               
     
biopharmaceutical products.
               
     
(Cost $530,142)
               
                       
 
3,855
 
Sonova Holding AG
   
1,026,391
     
0.81
%
     
Designs and produces
               
     
wireless analog and
               
     
digital in-the-ear and
               
     
behind-the-ear hearing aids
               
     
and miniaturized voice
               
     
communications systems.
               
     
(Cost $632,400)
               
                       
 
221,085
 
Spineart SA1,2,3
   
1,309,731
     
1.04
%
     
Designs and markets an
               
     
innovative full range of
               
     
spine products, including
               
     
fusion and motion
               
     
preservation devices,
               
     
focusing on easy to implant
               
     
high-end products to
               
     
simplify the surgical act.
               
     
(Cost $1,554,486)
               
                       
 
4,382
 
Tecan Group AG
   
1,680,995
     
1.33
%
     
Manufactures and
               
     
distributes laboratory
               
     
automation components
               
     
and systems. The products
               
     
are mainly used by research
               
     
and diagnostic laboratories.
               
     
(Cost $401,116)
               
           
7,655,502
     
6.07
%
Healthcare-Services — 0.72%
               
                       
 
11,300
 
Galenica AG
   
912,564
     
0.72
%
     
Retails pharmaceutical
               
     
products, and services
               
     
customers in Switzerland.
               
     
The Company offers
               
     
health, beauty, and related
               
     
products and services.
               
     
(Cost $902,693)
               
           
912,564
     
0.72
%
Industrials — 2.08%
               
                       
 
1,252
 
Belimo Holding AG1
   
624,426
     
0.50
%
     
Manufactures heating,
               
     
ventilation and air
               
     
conditioning equipment.
               
     
(Cost $144,479)
               



See Notes to Financial Statements.

12

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Industrials — (continued)
           
                       
 
234,000
 
OC Oerlikon Corp. AG
 
$
1,165,488
     
0.92
%
     
Manufactures industrial
               
     
equipment. The Company
               
     
produces protective
               
     
coatings for precision
               
     
tools and components,
               
     
equipment for textile
               
     
production, and propulsion
               
     
technology drive systems.
               
     
(Cost $2,574,223)
               
                       
 
2,000
 
VAT Group AG
   
827,139
     
0.66
%
     
Developer, manufacturer
               
     
and supplier of vacuum
               
     
valves, multi-valve modules
               
     
and edge-welded bellows
               
     
for use in semiconductor,
               
     
display and solar panel
               
     
manufacturing.
               
     
(Cost $564,824)
               
           
2,617,053
     
2.08
%
Insurance — 8.98%
               
                       
 
17,500
 
Baloise Holding AG
   
2,570,279
     
2.04
%
     
Offers group and individual
               
     
life, health, accident, liability
               
     
property, and transportation
               
     
insurance to customers in
               
     
Europe. The Company also
               
     
offers private banking and
               
     
asset management services.
               
     
(Cost $2,684,612)
               
                       
 
6,700
 
Helvetia Holding AG
   
906,164
     
0.72
%
     
Provides a broad range
               
     
of life, casualty, liability,
               
     
accident and transportation
               
     
insurance in Switzerland and
               
     
in other European countries.
               
     
The Company insures
               
     
individuals, property such
               
     
as vehicles and buildings,
               
     
and consumer goods and
               
     
personal belongings
               
     
(Cost $579,944)
               
                       
 
4,130
 
Swiss Life Holding AG
   
2,414,341
     
1.91
%
     
Provides life insurance
               
     
and institutional
               
     
investment management.
               
     
(Cost $1,109,486)
               
                       
 
11,430
 
Zurich Insurance
               
     
Group AG
   
5,428,499
     
4.31
%
     
Provides insurance-based
               
     
financial services. The
               
     
company offers general
               
     
and life insurance products
               
     
and services for individuals,
               
     
small businesses,
               
     
commercial enterprises,
               
     
mid-sized and large
               
     
corporations, and
               
     
multinational companies.
               
     
(Cost $3,698,494)
               
           
11,319,283
     
8.98
%



See Notes to Financial Statements.

13

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Machinery-Diversified — 0.50%
           
                       
 
26,500
 
Accelleron Industries AG
 
$
634,472
     
0.50
%
     
Develops, produces, and
               
     
services turbochargers
               
     
and large turbocharging
               
     
components. The Company
               
     
offers turbocharging
               
     
technologies and
               
     
optimization solutions for
               
     
engines thereby reducing
               
     
the environmental impact
               
     
with less fuel emissions.
               
     
(Cost $453,434)
               
           
634,472
     
0.50
%
Metal Fabricate/Hardware — 1.23%
               
                       
 
11,806
 
SFS Group AG
   
1,554,515
     
1.23
%
     
Provides automotive
               
     
products, building and
               
     
electronic components,
               
     
flat roofing and solar
               
     
fastening systems. The
               
     
company operates
               
     
production facilities in Asia,
               
     
Europe and North America.
               
     
(Cost $778,990)
               
           
1,554,515
     
1.23
%
Packaging & Containers — 1.49%
               
                       
 
68,000
 
SIG Combibloc Group AG
   
1,875,862
     
1.49
%
     
The company, through its
               
     
subsidiaries, manufactures
               
     
and produces bottling
               
     
machines and systems for
               
     
 the food and beverage
               
     
industries. The company
               
     
serves customers worldwide.
               
     
(Cost $746,444)
               
           
1,875,862
     
1.49
%
Pharmaceuticals — 22.30%
               
                       
 
142,229
 
Novartis AG
   
14,307,953
     
11.35
%
     
One of the leading
               
     
manufacturers of
               
     
branded and generic
               
     
pharmaceutical products.
               
     
(Cost $7,366,895)
               
                       
 
45,177
 
Roche Holding AG
   
13,810,886
     
10.95
%
     
Develops and manufactures
               
     
pharmaceutical and
               
     
diagnostic products.
               
     
Produces prescription
               
     
drugs to treat
               
     
cardiovascular, infectious
               
     
and autoimmune diseases
               
     
and for other areas
               
     
including dermatology
               
     
and oncology.
               
     
(Cost $8,109,729)
               
           
28,118,839
     
22.30
%
Private Equity — 2.19%
               
                       
 
2,928
 
Partners Group Holding AG
   
2,754,379
     
2.19
%
     
A global private markets
               
     
investment management
               
     
firm with investment
               
     
programs under
               
     
management in private
               
     
equity, private real estate,
               
     
private infrastructure and
               
     
private debt. The firm
               
     
manages a broad range of
               
     
customized portfolios for
               
     
an international clientele
               
     
of institutional investors.
               
     
Partners Group is
               
     
headquartered in
               
     
Zug, Switzerland.
               
     
(Cost $2,512,468)
               
           
2,754,379
     
2.19
%



See Notes to Financial Statements.

14

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — (continued)
           
             
Retail — 6.66%
           
                   
 
43,104
 
Cie Financiere
           
     
Richemont SA
 
$
7,306,457
     
5.80
%
     
Manufactures and retails
               
     
luxury goods. Produces
               
     
jewelry, watches, leather
               
     
goods, writing instruments
               
     
and men’s and
               
     
women’s wear.
               
     
(Cost $3,305,992)
               
                       
 
19,807
 
Swatch Group AG –
               
     
Registered Shares
   
1,088,151
     
0.86
%
     
Manufactures finished
               
     
watches, movements and
               
     
components. Produces
               
     
components necessary to
               
     
its various watch brand
               
     
companies. The company
               
     
also operates retail boutiques.
               
     
(Cost $1,353,585)
               
           
8,394,608
     
6.66
%
Semiconductors — 0.55%
               
                       
 
95,940
 
ams-OSRAM AG1
   
690,824
     
0.55
%
     
Designs and manufactures
               
     
advanced sensor solutions.
               
     
The company also delivers
               
     
a broad range of technology
               
     
solutions for consumer
               
     
electronics and
               
     
communication device
               
     
manufactures.
               
     
(Cost $1,266,338)
               
           
690,824
     
0.55
%
Transportation — 1.60%
               
                       
 
6,802
 
Kuehne + Nagel
               
     
International AG
   
2,012,507
     
1.60
%
     
Transports freight
               
     
worldwide. The company
               
     
operates sea, land, and
               
     
rail freight transportation
               
     
businesses and
               
     
warehousing and
               
     
distribution facilities.
               
     
(Cost $1,848,698)
               
           
2,012,507
     
1.60
%
     
Total Common Stock
               
     
(Cost $82,764,652)
   
121,378,355
     
96.28
%
                       
Preferred Stock — 0.03%
               
                 
Industrial Goods & Services — 0.03%
               
                       
 
500,863
 
SelFrag AG Class A1,2,3
   
35,270
     
0.03
%
     
Designs, manufactures and
               
     
sells industrial machines
               
     
and processes using
               
     
selective fragmentation
               
     
technology.
               
     
(Cost $1,932,198)
               
           
35,270
     
0.03
%
     
Total Preferred Stock
               
     
(Cost $1,932,198)
   
35,270
     
0.03
%



See Notes to Financial Statements.

15

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Limited Partnership — 0.91%
           
             
Biotechnology — 0.91%
           
                   
 
3,294,705
 
Aravis Biotech II,
           
     
Limited Partnership1,3,4
 
$
1,151,904
     
0.91
%
     
Makes early stage
               
     
venture investments
               
     
in the biotechnology &
               
     
pharmaceuticals industry.
               
     
(Cost $213,885)
               
           
1,151,904
     
0.91
%
     
Total Limited Partnership
               
     
(Cost $213,885)
   
1,151,904
     
0.91
%
                       
Short-Term Investment — 0.28%
               
                       
 
352,358
 
U.S. Bank Money
               
     
Market Deposit
               
     
Account, 1.55%5
   
352,358
     
0.28
%
     
(Cost $352,358)
               
           
352,358
     
0.28
%
     
Total Short-Term
               
     
Investment
               
     
(Cost $352,358)
   
352,358
     
0.28
%
                       
     
Total Investments6
               
     
(Cost $85,263,093)
   
122,917,887
     
97.50
%
                       
     
Other Assets
               
     
Less Liabilities6
   
3,149,241
     
2.50
%
     
Net Assets
 
$
126,067,128
     
100.00
%
                       
     
Net Asset Value Per Share:
               
     
($126,067,128 ÷12,990,705
               
     
shares outstanding,
               
     
$0.001 par value: 50 million
               
     
shares authorized)
 


    $
9.70
 



See Notes to Financial Statements.

16

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(continued)


1
Non-income producing security.
2
Value determined using significant unobservable inputs.
3
Illiquid.  There is not a public market for these securities in the United States or in any foreign jurisdiction, including Switzerland.  Securities are priced at Fair Value in accordance with the Fund’s valuation policy and procedures.  At the end of the period, the aggregate Fair Value of these securities amounted to $2,547,371 or 2.02% of the Fund’s net assets.  Additional information on these securities is as follows:

 
Security
Acquisition Date
 
Cost
 
 
Aravis Biotech II, Limited Partnership
July 31, 2007 – May 29, 2018
 
$
213,885
 
 
Eyesense AG – Common Shares
July 22, 2010 – October 3, 2011
   
3,007,048
 
 
SelFrag AG – Class A – Preferred Shares
December 15, 2011 – January 28, 2014
   
1,932,198
 
 
Spineart SA – Common Shares
December 22, 2010 - December 20, 2020
   
1,554,486
 
        
$
6,707,617
 

4
Affiliated Company. An affiliated company is a company in which the Fund has ownership of at least 5% of the company’s outstanding voting securities or an equivalent interest in the company. Details related to affiliated company holdings are as follows:

   
Value
                     
Change in
               
Value
 
   
as of
   
Gross
   
Gross
   
Realized
   
Unrealized
   
Corporate
   
Interest
   
as of
 
 
Name of Issuer
12/31/22
   
Additions
   
Reductions
   
Gain/(Loss)
   
Gain/(Loss)
   
Actions
   
Income
   
6/30/23
 
 
Aravis Biotech II,
                                             
 
Limited Partnership
$
1,302,142
   
$
   
$
   
$
217,940
   
$
1,446,061
   
$
(1,814,239
)
 
$
   
$
1,151,904
 
   
$
1,302,142
   
$
   
$
   
$
217,940
   
$
1,446,061
   
$
(1,814,239
)
 
$
   
$
1,151,904
 

5
Rate shown is the seven day annualized yield as of June 30, 2023.
6
All of the Fund’s investments and other assets are pledged as collateral in accordance with a credit agreement with U.S. Bank, National Association.



See Notes to Financial Statements.

17

THE SWISS HELVETIA FUND, INC.


Schedule of Investments by Industry (Unaudited)
June 30, 2023
(concluded)


PORTFOLIO HOLDINGS
 
% of Net Assets as of June 30, 2023
 
    Pharmaceuticals
22.30%
    Food
21.40%
    Insurance
8.98%
    Retail
6.66%
    Healthcare-Products
6.07%
    Diversified Financial Services
3.85%
    Biotechnology
3.54%
    Building Materials
3.41%
    Banks
2.61%
    Private Equity
2.19%
    Electronic Components & Equipment
2.15%
    Industrials
2.08%
    Electric
2.06%
    Computers
1.82%
    Transportation
1.60%
    Chemicals
1.50%
    Packaging & Containers
1.49%
    Metal Fabricate/Hardware
1.23%
    Healthcare-Services
0.72%
    Semiconductors
0.55%
    Machinery-Diversified
0.50%
    Advertising
0.48%
    Short-Term Investment
0.28%
    Industrial Goods & Services
0.03%
Other Assets Less Liabilities
    2.50%
 
100.00%
TOP 10 PORTFOLIO HOLDINGS
 
% of Net Assets as of June 30, 2023
 
Nestle SA
18.49%
Novartis AG
11.35%
Roche Holding AG
10.95%
Cie Financiere Richemont SA
5.80%
Zurich Insurance Group AG
4.31%
Lonza Group AG
2.39%
UBS Group AG
2.23%
Partners Group Holding AG
2.18%
BKW AG
2.06%
Baloise Holding AG
2.04%



See Notes to Financial Statements.

18

THE SWISS HELVETIA FUND, INC.


Statement of Assets and Liabilities (Unaudited)
June 30, 2023




Assets:
     
Investments in unaffiliated issuers, at value (cost $85,049,208)
 
$
121,765,983
 
Investments in affiliated issuers, at value (cost $213,885)
   
1,151,904
 
    Total Investments, at value (cost $85,263,093)
   
122,917,887
 
Foreign currency (cost $3,656,664)
   
3,704,886
 
Tax reclaims receivable
   
1,311,565
 
Interest receivable
   
3,561
 
Prepaid expenses
   
38,490
 
    Total assets
   
127,976,389
 
         
Liabilities:
       
Accrued Fees and Expenses:
       
Payable for investments purchased
   
1,622,152
 
    Investment advisory
   
74,974
 
    Directors
   
73,477
 
    Legal
   
55,483
 
    Audit
   
27,512
 
    Custody
   
2,411
 
    Other
   
53,252
 
    Total liabilities
   
1,909,261
 
    Net assets
 
$
126,067,128
 
         
Composition of Net Assets:
       
Paid-in capital
   
88,897,845
 
Total distributable earnings
   
37,169,283
 
Net assets
 
$
126,067,128
 
         
Net Asset Value Per Share:
       
($126,067,128 ÷ 12,990,705 shares outstanding,
       
  $0.001 par value: 50 million shares authorized)
 
$
9.70
 



See Notes to Financial Statements.

19

THE SWISS HELVETIA FUND, INC.


Statement of Operations (Unaudited)
For the Six Months Ended June 30, 2023




Investment Income:
     
Dividend (less of foreign tax withheld of $459,257)
 
$
2,744,194
 
Interest income
   
27,386
 
    Total income
   
2,771,580
 
Expenses:
       
Investment advisory fees (Note 2)
   
431,615
 
Directors’
   
155,026
 
Legal (Note 3)
   
107,578
 
Officer
   
67,173
 
Administration (Note 3)
   
62,615
 
Delaware franchise tax (Note 9)
   
61,500
 
Printing and shareholder reports
   
34,210
 
Audit (Note 3)
   
27,512
 
Custody (Note 3)
   
25,349
 
Insurance
   
24,647
 
Transfer agency (Note 3)
   
16,354
 
Commitment fee (Note 9)
   
10,487
 
Miscellaneous
   
10,200
 
    Total expenses
   
1,034,266
 
    Net investment income
   
1,737,314
 
Realized and Unrealized Gains on Investments and Foreign Currency Translations:
       
Net realized gain from:
       
    Investments in unaffiliated issuers
   
86,390
 
    Foreign currency transactions
   
191,590
 
    Total net realized gain from unaffiliated and
       
      affiliated issuers and foreign currency transactions
   
277,980
 
Net change in unrealized appreciation from:
       
    Investments in unaffiliated issuers
   
11,259,227
 
    Investments in affiliated issuers
   
1,446,061
 
    Foreign currency translations
   
76,551
 
    Total net change in unrealized appreciation from
       
      unaffiliated and affiliated issuers, and foreign currency translations
   
12,781,839
 
    Net Realized and Unrealized Gain on
       
      Investments and Foreign Currency Translations
   
13,059,819
 
Net Increase in Net Assets from Operations
 
$
14,797,133
 



See Notes to Financial Statements.

20

THE SWISS HELVETIA FUND, INC.


Statement of Cash Flows (Unaudited)
For the Six Months Ended June 30, 2023




Cash flows from operating activities:
     
Net increase in net assets applicable to common shareholders
 
$
14,797,133
 
Adjustments to reconcile net increase in net assets applicable to
       
  common shareholders resulting from operations to net cash
       
  provided by operating activities:
       
    Purchases of investments
   
(6,507,419
)
    Proceeds from sales of investments
   
9,435,766
 
    Net purchases and sales of short-term investments
   
(21,328
)
    Return of capital distributions received from underlying investments
   
1,603,805
 
    Increase in tax reclaims receivable
   
(13,677
)
    Increase in dividends and interest receivable
   
(614
)
    Increase in other assets
   
(18,054
)
    Increase in payable for investments purchased
   
1,622,152
 
    Increase in payable to Adviser
   
4,717
 
    Decrease in accrued expenses and other liabilities
   
(42,023
)
    Net realized gains from investments
   
(86,390
)
    Net change in unrealized appreciation (depreciation) from investments
   
(12,705,288
)
    Net cash provided by operating activities
   
8,068,780
 
         
Cash flows from financing activities:
       
Distributions paid to common shareholders
   
(3,216,720
)
Repurchase of common stock
   
(1,687,598
)
Net cash used in financing activities
   
(4,904,318
)
Net change in cash
 
$
3,164,462
 
         
Cash:
       
Beginning of period*
   
540,424
 
End of period*
 
$
3,704,886
 
         
Cash financing activities not included herein consist of interest paid
   
10,487
 

*  Cash included in the Statement of Cash Flows comprised of foreign currency.



See Notes to Financial Statements.

21

THE SWISS HELVETIA FUND, INC.


Statement of Changes in Net Assets


   
For the
       
   
Six Months Ended
   
For the
 
   
June 30, 2023
   
Year Ended
 
   
(Unaudited)
   
December 31, 2022
 
Increase (Decrease) in Net Assets:
           
Operations:
           
Net investment income
 
$
1,737,314
   
$
920,814
 
Total net realized gain from unaffiliated and
               
  affiliated issuers and foreign currency transactions
   
277,980
     
2,080,182
 
Total net change in unrealized appreciation
               
  (depreciation) from unaffiliated and affiliated issuers,
               
  foreign currency and foreign currency translations
   
12,781,839
     
(30,399,182
)
Net increase (decrease) in net assets from operations
   
14,797,133
     
(27,398,186
)
Distributions to Stockholders:
               
From earnings
   
(3,216,720
)
   
(2,977,194
)
From return of capital
   
     
(5,241,653
)
Total distributions to stockholders
   
(3,216,720
)
   
(8,218,847
)
Capital Stock Transactions:
               
Value of shares repurchased through
               
  stock repurchase program (Note 6)
   
(1,687,598
)
   
(120,928
)
Total decrease from capital share transactions
   
(1,687,598
)
   
(120,928
)
Total increase (decrease) in net assets
   
9,892,815
     
(35,737,961
)
Net Assets:
               
Beginning of period
   
116,174,313
     
151,912,274
 
End of period
 
$
126,067,128
   
$
116,174,313
 



See Notes to Financial Statements.

22

THE SWISS HELVETIA FUND, INC.


Financial Highlights


   
For the Six
                               
   
Months Ended
                               
   
June 30, 2023
   
For the Years Ended December 31,
 
   
(Unaudited)
   
2022
   
2021
   
2020
   
2019
   
2018
 
Per Share Operating Performance:
                                   
Net asset value at the beginning of period
 
$
8.80
   
$
11.50
   
$
10.45
   
$
9.71
   
$
7.96
   
$
14.10
 
Income from Investment Operations:
                                               
Net investment income1
   
0.13
     
0.07
     
0.05
     
0.05
     
0.01
     
0.14
 
Net realized and unrealized
                                               
  gain (loss) on investments2
   
0.98
     
(2.15
)
   
1.58
     
1.24
     
1.88
     
(1.35
)
Total from investment activities
   
1.11
     
(2.08
)
   
1.63
     
1.29
     
1.89
     
(1.21
)
Gain from tender offer
   
     
     
     
     
     
0.30
4 
Capital change resulting from
                                               
  the issuance of fund shares
   
     
     
     
     
     
(0.12
)4
Anti-dilutive effect of common
                                               
  share repurchase program
   
0.03
     
0.00
5 
   
     
0.01
     
     
 
Less Distributions:
                                               
Net investment income
   
(0.24
)
   
(0.06
)
   
(0.06
)
   
(0.08
)
   
(0.12
)
   
(0.10
)
Net realized gains
   
     
(0.16
)
   
(0.09
)
   
     
(0.02
)
   
(5.01
)
Return of Capital
   
     
(0.40
)
   
(0.43
)
   
(0.48
)
   
     
 
Total distributions
   
(0.24
)
   
(0.62
)
   
(0.58
)
   
(0.56
)
   
(0.14
)
   
(5.11
)
Net asset value at end of period
 
$
9.70
   
$
8.80
   
$
11.50
   
$
10.45
   
$
9.71
   
$
7.96
 
Market value per share at the end of period
 
$
8.22
   
$
7.56
   
$
9.94
   
$
8.94
   
$
8.41
   
$
6.90
 
Total Investment Returns:3,6
                                               
Based on market value per share
   
12.16
%
   
-17.62
%
   
18.25
%
   
14.18
%
   
24.00
%
   
-10.90
%
Based on net asset value per share
   
13.16
%
   
-17.97
%
   
16.09
%
   
14.29
%
   
23.80
%
   
-6.98
%
Ratios to Average Net Assets:7
                                               
Net expenses
   
1.68
%9
   
1.68
%8
   
1.40
%
   
1.80
%
   
2.13
%
   
1.44
%
Gross expenses
   
1.68
%9
   
1.68
%8
   
1.40
%
   
1.80
%
   
2.13
%
   
1.44
%
Net investment income
   
2.82
%
   
0.74
%
   
0.48
%
   
0.48
%
   
0.10
%
   
1.12
%
Supplemental Data and Ratios
                                               
Net assets at end of period (000’s)
 
$
126,067
   
$
116,174
   
$
151,912
   
$
138,040
   
$
128,864
   
$
105,577
 
Average net assets during the period (000’s)
 
$
124,341
   
$
123,684
   
$
144,019
   
$
125,666
   
$
118,960
   
$
305,270
 
Portfolio turnover rate
   
5
%
   
15
%
   
11
%
   
12
%
   
18
%
   
21
%

1
Calculated using the average shares method.
2
Includes net realized and unrealized currency gains and losses.
3
Total investment return based on market value differs from total investments return based on net asset value due to changes in the relationship between the market value of the Fund’s shares and its NAV per share.
4
On November 20, 2018, the Fund accepted for cash purchase 24,638,918 shares of the Fund’s common stock at a price equal to $7.86 per share, which represented 98% of the Fund’s NAV per share of $8.02 as of the close of the regular trading session of the New York Stock Exchange on November 19, 2018. As a result of the purchase of the 24,638,918 shares, the Fund had 13,267,111 shares of common stock outstanding as of November 20, 2018.
5
Less than 0.5 cents per share.
6
Not annualized for years less than one year.
7
Annualized for years less than one year.
8
If interest expense and commitment fees had been excluded, the expense ratios would have been lower by 0.05% for the year ended December 31, 2022.
9
If commitment fees had been excluded, the expense ratios would have been lower by 0.02% for the six months ended June 30, 2023.



See Notes to Financial Statements.

23

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited)

 
Note 1—Organization and Significant Accounting Policies
 
A. Organization
The Swiss Helvetia Fund, Inc. (the “Fund”) is registered under the Investment Company Act of 1940, as amended (the “Act”), as a non-diversified, closed-end management investment company. The Fund is organized as a corporation under the laws of the State of Delaware.
 
The investment objective of the Fund is to seek long-term growth of capital through investment in equity and equity-linked securities of Swiss companies. The Fund may also acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
 
B. Securities Valuation
The Fund values its investments in accordance with accounting principles generally accepted in the United States (“GAAP”).
 
When valuing listed equity securities, the Fund uses the last sale price on the securities exchange or national securities market on which such securities primarily are traded (the “Primary Market”) prior to the calculation of the Fund’s net asset value (“NAV”). When valuing equity securities that are not listed (except privately-held companies and private equity limited partnerships) or that are listed but have not traded on a day on which the Fund calculates its NAV, the Fund uses the mean between the bid and asked prices for that day. If there are no asked quotations for such a security, the value of such security will be the most recent bid quotation on the Primary Market on that day. On any day when a security’s Primary Market is closed because of a local holiday or other scheduled closure, but the New York Stock Exchange is open, the Fund may use the prior day’s closing prices to value such security regardless of the length of the scheduled closing.
 
When valuing fixed-income securities, if any, the Fund uses the last bid price prior to the calculation of the Fund’s NAV. If there is no current bid price for a fixed-income security, the value of such security will be the mean between the last quoted bid and asked prices on that day. Overnight and certain other short-term fixed-income securities with maturities of less than 60 days will be valued by the amortized cost method, unless it is determined that the amortized cost method would not represent the fair value of such security.
 
In accordance with Rule 2a-5 under the Act, the Fund’s Board of Directors (the “Board”) has designated the Fund’s investment adviser, Schroder Investment Management North America Inc., as the Fund’s valuation designee (the “Valuation Designee”) for purposes of determining fair value in good faith of securities for which market quotations are not readily available, or for which the market quotations that are available are considered unreliable (a “Fair Value”). The Valuation Designee may use the Fund’s fair valuation procedures to establish the Fair Value of securities when, for example, a significant event occurs between the time the market closes and the time the Valuation Designee values its investments. After consideration of various factors, the Valuation Designee may value the securities at their last reported price or at some other value.
 
Swiss exchange-listed options, if any, including Eurex-listed options, are valued at their most recent sale price (latest bid for long options and the latest ask for short options) on the Primary Market, or
 

24

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


if there are no such sales, at the average of the most recent bid and asked quotations on such Primary Market, or if such quotations are not available, at the last bid quotation (in the case of purchased options) or the last asked quotation (in the case of written options). If, however, there are no such quotations, such options will be valued using the implied volatilities observed for similar options or from aggregated data as an input to a model. Options traded in the over-the-counter market, if any, are valued at the price communicated by the counterparty to the option, which typically is the price at which the counterparty would close out the transaction. Option contracts, if any, that are neither exchange-listed nor traded in the over-the-counter market, and where no broker can provide a quote or approved pricing vendor a price, may be valued using the implied volatilities observed for similar instruments or from aggregated market data received from services (e.g., Bloomberg) as an input to a widely accepted model.
 
The Fund is permitted to invest in investments that do not have readily available market quotations. For such investments, the Valuation Designee determines their Fair Value. The aggregate value of these investments amounted to $2,547,371, or 2.02% of the Fund’s net assets at June 30, 2023 and are listed in Note 3 to the Schedule of Investments.
 
Various inputs are used to determine the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:
 
Level 1—
unadjusted quoted prices in active markets for identical assets and liabilities
   
Level 2—
other significant observable inputs (including quoted prices of similar securities, interest rates, prepayment speeds, credit risk, etc.)
   
Level 3—
significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
 
The following is a summary of the inputs used to value the Fund’s investments as of June 30, 2023:
 
         
Level 2
   
Level 3
   
Investments
       
   
Level 1
   
Other Significant
   
Significant
   
Valued at
       
   
Quoted Prices
   
Observable Inputs
   
Unobservable Inputs
   
NAV**
   
Total
 
Investments in Securities*
                             
    Common Stock
 
$
120,018,158
   
$
   
$
1,360,197
   
$
   
$
121,378,355
 
    Preferred Stock
   
     
     
35,270
     
     
35,270
 
    Limited Partnership
   
     
     
     
1,151,904
     
1,151,904
 
    Money Market Deposit Account
   
     
352,358
     
     
     
352,358
 
Total Investments in Securities
 
$
120,018,158
   
$
352,358
   
$
1,395,467
   
$
1,151,904
   
$
122,917,887
 

*
Please see the Schedule of Investments for industry classifications.
**
As of June 30, 2023, certain of the Fund’s investments were valued using net asset value (“NAV”) per share (or its equivalent) as a practical expedient for fair value and have been excluded from the fair value hierarchy in accordance with ASU 2015-07. The fair value amount presented in this table is intended to permit reconciliation of the amounts presented in the fair value hierarchy to the amounts presented in the statement of assets and liabilities.


25

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


The Fund values its investment in a private equity limited partnership in accordance with Accounting Standards Codification 820-10-35, “Investments in Certain Entities that Calculate Net Asset Value Per Share (Or its Equivalent)” (“ASC 820-10-35”). ASC 820-10-35 permits a reporting entity to measure the fair value of an investment that does not have a readily determinable fair value, based on the NAV of the investment as a practical expedient, without further adjustment, unless it is probable that the investment will be sold at a value significantly different than the NAV. If the NAV of the investment is not as of the Fund’s measurement date, then the NAV should be adjusted to reflect any significant events that may change the valuation. Inputs and valuation techniques for these adjustments may include fair valuations of the partnership and its portfolio holdings provided by the partnership’s general partner or manager, other available information about the partnership’s portfolio holdings, values obtained on redemption from other limited partners, discussions with the partnership’s general partner or manager and/or other limited partners and comparisons of previously-obtained estimates to the partnership’s audited financial statements. In using the unadjusted NAV as a practical expedient, certain attributes of the investment that may impact its fair value are not considered. Attributes of those investments include the investment strategies of the privately held companies and may also include, but are not limited to, restrictions on the investor’s ability to redeem its investments at the measurement date and any unfunded commitments.
 
Inputs and valuation techniques used by the Valuation Designee to value the Fund’s Level 3 investments in privately-held companies may include the following: acquisition cost; fundamental analytical data; discounted cash flow analysis; nature and duration of restrictions on disposition of the investment; public trading of similar securities of similar issuers; economic outlook and condition of the industry in which the issuer participates; financial condition of the issuer; and the issuer’s prospects, including any recent or potential management or capital structure changes. Although these valuation inputs may be observable in the marketplace as is characteristic of Level 2 investments, the privately-held companies, categorized as Level 3 investments, generally are highly illiquid in terms of resale.
 
When valuing Level 3 investments, management also may consider potential events that could have a material impact on the operations of a privately-held company. Not all of these factors may be considered or available, and other relevant factors may be considered on an investment-by-investment basis. The table below summarizes the techniques and unobservable inputs for the valuation of Level 3 investments.
 


26

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


Quantitative Information about certain Level 3 Fair Value Measurements

   
Value at
           
   
June 30, 2023
 
Valuation Technique
Unobservable Inputs
 
Range1
 
Healthcare-Products
               
    EyeSense AG, Series A—Common Shares
 
$
50,466
 
Market approach
Latest round of financing with
 
70-90%

             
an additional discount as a
     
             
going concern using a
     
             
probability weighted approach
     
    Spineart SA—Common Shares
   
1,309,731
 
Market approach
Based on listed trading
 
15-25%

             
multiples, cross checked to
     
             
secondary share purchase
     
             
with additional discount for
     
             
lack of marketability
     
Industrial Goods & Services
                 
    SelFrag AG Class A—Preferred Shares
   
35,270
 
Market approach
Latest round of financing
     
             
with an additional discount
     
             
for lack of marketability
 
40-60%

Total
 
$
1,395,467
           

1
Significant changes in any of these ranges would result in a significantly higher or lower fair value measurement. A change in the discount rate is accompanied by a directionally opposite change in fair value.

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.
 
   
Common
   
Preferred
       
   
Stock
   
Stock
   
Total
 
Balance as of December 31, 2022
 
$
1,384,260
   
$
48,722
   
$
1,432,982
 
Change in Unrealized Appreciation/Depreciation
   
(24,063
)
   
(13,452
)
   
(37,515
)
Net Realized Gain (Loss)
   
     
     
 
Gross Purchases
   
     
     
 
Gross Sales
   
     
     
 
Transfer out of Level 3
   
     
     
 
Balance as of June 30, 2023
 
$
1,360,197
   
$
35,270
   
$
1,395,467
 
Change in unrealized appreciation (depreciation) during the period
                       
  for Level 3 investments held at June 30, 2023
   
(24,063
)
   
(13,452
)
   
(37,515
)

C. Derivative Instruments
GAAP requires enhanced disclosure that enables investors to understand how and why an entity uses derivatives, how derivatives are accounted for, and how derivative instruments affect an entity's results of operations and financial position.
 

27

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


The Fund did not hold any derivative instruments during the period ended June 30, 2023.
 
D. Securities Transactions and Investment Income
Securities transactions are recorded on the trade date. Realized gains and losses are determined by comparing the proceeds of a sale or the cost of a purchase to a specific offsetting transaction.
 
Dividend income, net of any foreign taxes withheld, is recorded on the ex-dividend date. Interest income, including amortization of premium and accretion of discount, is accrued daily. Estimated expenses are also accrued daily.
 
The Fund records Swiss withholding tax as a reduction of dividend income, net of any amount reclaimable from Swiss tax authorities in accordance with the tax treaty between the United States and Switzerland.
 
Distributions received from securities that represent a return of capital or capital gains are recorded as a reduction of cost of investment and/or as a realized gain.
 
E. Distributions
The Fund makes distributions at least annually to the extent it has any federally taxable net investment income and makes distributions of any net realized capital gains to the extent that they exceed any capital loss carryforwards. The Fund determines the size and nature of these distributions in accordance with provisions of the Internal Revenue Code of 1986, as amended (the “Code”). The Fund records dividends and distributions on the ex-dividend date.
 
In May 2018, the Board adopted a managed distribution policy that permits the Fund to distribute long-term capital gains more frequently than once per year as permitted by the Act. Distributions under the managed distribution plan may consist of net investment income, net realized short-term capital gains, net realized long-term capital gains and, to the extent necessary, return of capital (or other capital sources). In August 2018, the Board suspended until further notice any distributions that would otherwise be payable pursuant to the managed distribution policy. In November 2019, the Board approved the resumption of distributions pursuant to the managed distribution policy. The Board may change or terminate the managed distribution policy at any time without prior notice to Fund stockholders, which could have an adverse effect on the market price of the Fund’s shares. On March 31, 2023 and June 30, 2023, in accordance with the Fund’s managed distribution policy as then in effect, the Fund paid quarterly distributions of $0.12285 per share of the Fund’s common stock to all stockholders of record as of March 22, 2023 and June 21, 2023, respectively.
 
F. Federal Income Taxes
The Fund’s policy is to continue to comply with the requirements of the Code that are applicable to regulated investment companies and to distribute all its taxable income to its stockholders. Therefore, no federal income tax provision is required.
 

28

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


Income and capital gain distributions are determined in accordance with federal income tax regulations, which may differ from GAAP. See Note 5 for federal income tax treatment of foreign currency gains/losses.
 
Management has analyzed the Fund’s tax positions taken on federal income tax returns for all open tax years and has concluded that no provision for federal income tax is required in the Fund’s financial statements. The Fund files federal tax returns which remain open for examination generally for the current year and the three prior years. In addition, the Fund holds investments in Switzerland and other foreign tax jurisdictions. Withholding taxes on foreign interest and dividends have been provided for in accordance with each applicable country’s tax rules and rates.
 
G. Foreign Currency Translation
The Fund maintains its accounting records in U.S. dollars. The Fund’s assets are invested primarily in Swiss equities. In addition, the Fund can make its temporary investments in Swiss franc-denominated bank deposits, short-term debt securities and money market instruments. Substantially all income received by the Fund is in Swiss francs. The Fund’s NAV, however, is reported, and distributions from the Fund are made, in U.S. dollars, resulting in gain or loss from currency conversions in the ordinary course of business. Historically, the Fund has not entered into transactions designed to reduce currency risk and does not intend to do so in the future. The cost basis of foreign denominated assets and liabilities is determined on the date that they are first recorded within the Fund and translated to U.S. dollars. These assets and liabilities are subsequently valued each day at prevailing exchange rates. The difference between the original cost and current value denominated in U.S. dollars is recorded as unrealized foreign currency gain/loss. In valuing securities transactions, the receipt of income and the payment of expenses, the Fund uses the prevailing exchange rate on the transaction date.
 
Net realized and unrealized gains and losses on foreign currency shown in the Fund’s financial statements result from the sale of foreign currencies, from currency gains or losses realized between the trade and settlement dates of securities transactions, and from the difference between the amounts of dividends, interest and foreign withholding taxes recorded on the Fund’s books and the U.S. dollar equivalent of the amounts actually received or paid.
 
When calculating realized and unrealized gains or losses on investments, the Fund does not separate the gain or loss attributable to changes in the foreign currency price of the security from the gain or loss attributable to the change in the U.S. dollar value of the foreign currency. Other foreign currency translations resulting in realized and unrealized gain or loss are disclosed separately.
 
H. Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
 


29

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)

 
I. Concentration of Market Risk
The Fund primarily invests in securities of Swiss issuers. Such investments may carry certain risks not ordinarily associated with investments in securities of U.S. issuers. These risks include future political and economic developments, unfavorable movements in the Swiss franc relative to the U.S. dollar, and the possible imposition of exchange controls and changes in governmental law and restrictions. In addition, concentrations of investments in securities of issuers located in a specific region expose the Fund to the economic and government policies of that region and may increase risk compared to a fund whose investments are more diversified.
 
Note 2—Fees and Transactions with Affiliates
Schroder Investment Management North America Inc. (“SIMNA”) and its affiliate, Schroder Investment Management North America Limited (“SIMNA Ltd” and together with SIMNA, “Schroders”), serve as the Fund’s investment adviser and investment sub-adviser, respectively. The Fund pays SIMNA an annual advisory fee of 0.70% of the Fund’s average month-end net assets up to $250 million, 0.60% of such assets in excess of $250 million and up to $350 million, 0.55% of such assets in excess of $350 million and up to $450 million, 0.50% of such assets in excess of $450 million and up to $550 million, and 0.45% of such assets in excess of $550 million. As compensation for its investment sub-advisory services, SIMNA Ltd receives 63% of the advisory fee paid by the Fund to SIMNA.
 
The Fund pays each Director who is not an “interested person” (as such term is defined in the Act) of the Fund or Schroders (“Non-Interested Directors”), $42,000 annually in compensation, except for the Chairman of the Board to whom the Fund pays an annual fee of $56,000 and for the Chairs of the Audit, the Pricing and the Governance/Nominating Committees to each of whom the Fund pays an annual fee of $48,000. In addition, the Fund pays each Non-Interested Director $2,000 for each Board meeting attended in person, and $750 for each Board meeting attended by telephone. Each Director who is a member of a Committee will be paid a fee of $750 for each Committee meeting attended, whether in person or by telephone. The Board or a Committee may establish ad hoc committees or subcommittees. Any Committee or sub-committee member may be compensated by the Fund for incremental work outside of the regular meeting process based on the value determined to be added to the Fund. In July 2018, the Board approved a change to its By-Laws and Board committee charters to provide that each Director who is not an “interested person” of Schroders or its affiliates will be entitled to receive the above fees. The Fund pays an annual fee of $25,000 to the President and Chief Executive Officer, $30,000 to the Chief Financial Officer, $25,000 to the Secretary and $54,000 to the Chief Compliance Officer of the Fund.
 
Note 3—Other Service Providers
Equiniti Trust Company, LLC is the Fund’s transfer agent. U.S. Bank, N.A. serves as the Fund’s custodian and U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services, provides administration and portfolio accounting services to the Fund. The Fund pays these service providers’ fees, which are accrued daily and paid monthly.
 


30

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


In addition to its other service provider fees, the Fund incurs certain professional fees, including fees of its outside legal counsel as well as fees of its independent registered public accounting firm. Those fees vary depending on the nature of the Fund’s activities each year.
 
Note 4—Capital Share Transactions
The Fund is authorized to issue up to 50 million shares of capital stock. Transactions in capital shares were as follows:
 
   
For the Period Ended
   
For the Year Ended
 
   
June 30, 2023
   
December 31, 2022
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Dividends Reinvested
   
   
$
     
   
$
 
Repurchased through Stock Repurchase Program (Note 6)
   
(205,045
)
   
(1,687,598
)
   
(16,504
)
   
(120,928
)
Repurchased from Tender Offer (Note 7)
   
     
     
     
 
Net Increase/(Decrease)
   
(205,045
)
 
$
(1,687,598
)
   
(16,504
)
 
$
(120,928
)

Note 5—Federal Income Tax and Investment Transactions
The tax character of distributions paid during 2022 and 2021 were as follows:
 
   
2022
   
2021
 
Ordinary Income
 
$
810,137
   
$
907,509
 
Return of Capital
   
5,241,653
     
5,667,420
 
Long-Term Capital Gains
   
2,167,057
     
1,076,948
 
Total
 
$
8,218,847
   
$
7,651,877
 

Under current tax law, capital losses and specified ordinary losses realized after October 31 may be deferred and treated as occurring on the first business day of the following fiscal year. The Fund did not defer any post-October capital and currency losses and other late-year deferrals for the fiscal year ended December 31, 2022.
 
Capital loss carryovers retain their character as either long-term capital losses or short-term capital losses and are applied as a new loss on the first day of the immediately succeeding tax year. During the tax year ending December 31, 2022, the Fund did not have any capital loss carryovers.
 


31

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


At December 31, 2022, the components of distributable earnings on a tax basis were as follows:
 
Tax cost of investments
 
$
88,977,674
 
Unrealized appreciation
   
37,699,931
 
Unrealized depreciation
   
(12,040,572
)
Net unrealized appreciation
   
25,659,359
 
Net unrealized on foreign currency
   
4,375
 
Undistributed ordinary income
   

Undistributed long-term capital gains
   
 
Distributable earnings
   
 
Other accumulated losses
   
(74,864
)
Total distributable earnings
 
$
25,588,870
 

The differences between book basis and tax basis distributable earnings are primarily attributable to tax deferral of wash sales and investments in partnerships.
 
Gains and losses from foreign currency transactions are treated as ordinary income and loss, respectively, for federal income tax purposes.
 
The following summarizes all distributions declared by the Fund during the year ended December 31, 2022:
 
Record Date
 
Payable Date
 
Ordinary Income
   
Return of Capital
   
ST Cap Gains
   
LT Cap Gains
   
Total Distribution
 
3/22/22
 
3/31/22
 
$
0.01641201
   
$
0.10618706
   
$
   
$
0.04390093
   
$
0.16650
 
6/21/22
 
6/30/22
   
0.01641201
     
0.10618706
     
     
0.04390093
     
0.16650
 
9/21/22
 
9/30/22
   
0.01641201
     
0.10618706
     
     
0.04390093
     
0.16650
 
12/20/22
 
12/30/22
   
0.01210940
     
0.07834883
     
     
0.03239176
     
0.12285
 
                                       
$
0.62235
 

There were no reclassifications made between total distributable earnings and paid-in capital.
 
Note 6—Stock Repurchase Program
Pursuant to authorization by the Board, the Fund began open market purchases of its common stock on the New York Stock Exchange in 1999. The Board has authorized a stock repurchase program permitting such purchases by the Fund in each subsequent year, except for 2014. The principal purpose of the stock repurchase program has been to enhance stockholder value by increasing the Fund’s NAV per share.
 
On December 7, 2018, the Fund announced the Board’s approval of the Fund’s stock repurchase program for 2019. Under the 2019 program, the Fund was authorized to make open-market repurchases of its common stock of up to 250,000 shares. The Fund did not repurchase any common stock pursuant to the program during the year ended December 31, 2019. On December 13, 2019, the Fund announced the Board’s approval of the Fund’s stock repurchase plan for 2020 of up to 250,000 shares of common stock. During the year ended December 31, 2020, the Fund
 


32

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (continued)


repurchased 54,857 shares of its capital stock in the open market at a cost of $449,102. The weighted average discount of these purchases comparing the average purchase price to net asset value at the close of the New York Stock Exchange was 16.33%.
 
On December 12, 2020, the Board approved the Fund’s stock repurchase plan for 2021 of up to 250,000 shares of common stock. The Fund did not repurchase any common stock pursuant to the plan during the year ended December 31, 2021. On December 10, 2021, the Board approved the Fund’s stock repurchase program for 2022 of up to 250,000 shares of common stock. During the year ended December 31, 2022, the Fund repurchased 16,504 shares of its capital stock in the open market at a cost of $120,928. The weighted average discount of these purchases comparing the average purchase price to net asset value at the close of the New York Stock Exchange was 14.09%.
 
On December 15, 2022, the Board approved the Fund’s stock repurchase program for 2023 of up to 250,000 shares of common stock. During the six months ended June 30, 2023, the Fund repurchased 205,045 shares of its capital stock in the open market at a cost of $1,687,598. The weighted average discount of these purchases comparing the average purchase price to net asset value at the close of the New York Stock Exchange was 16.32%.
 
The Fund intends to repurchase shares of its common stock, at such times and in such amounts as is deemed advisable and in accordance with applicable law, subject to various factors, including the limitations imposed by the federal securities laws governing the repurchase of an issuer’s stock by the issuer and the Fund’s available cash to repurchase shares of the Fund’s common stock below NAV.
 
Note 7—Capital Commitments
As of June 30, 2023, the Fund maintains an illiquid investment in one private equity limited partnership. This investment appears in the Fund’s Schedule of Investments. The Fund’s capital commitment for this partnership is shown in the table below:
 
 
Original Capital
Unfunded
Investments
Commitment*
Commitment*
Private Equity Limited Partnership—International(a)
   
Aravis Biotech II, Limited Partnership
$3,632,706
$  —

*
The original capital commitment represents 3,250,000 Swiss francs, which has been fully funded as of December 31, 2022. The Swiss franc/U.S. dollar exchange rate as of June 30, 2023 was used for conversion and equaled 0.89465 as of such date.
(a)
This category consists of one private equity limited partnership that invests primarily in venture capital companies in the biotechnology and medical technology sectors. There is no redemption right for the interest in this limited partnership. Instead, the nature of investments in this category is that distributions are received through the realization of the underlying assets of the limited partnership.

Note 8—Investment Transactions
The aggregate cost of purchases and proceeds from sales of investments, other than short-term obligations, for the six months ended June 30, 2023 were $6,507,419 and $9,435,766, respectively.
 


33

THE SWISS HELVETIA FUND, INC.


Notes to Financial Statements (Unaudited) (concluded)

 
Note 9—Credit Facility
The Fund and U.S. Bank, National Association (“U.S. Bank”) are party to a credit agreement, dated as of March 29, 2023, pursuant to which U.S. Bank has made available to the Fund a $15,000,000 committed credit facility. Interest is charged on outstanding borrowings under the credit facility at the annual rate of the prime rate minus 2.10%. The Fund is responsible for paying a commitment fee to U.S. Bank on the unused portion of the credit facility at an annual rate of (i) 0.250% of the unused amount of the credit facility if the used amount of the credit facility is less than 75% of the credit facility or (ii) 0.175% of the unused amount of the credit facility if the used amount of the credit facility is 75% or more of the credit facility. The credit facility will terminate on March 27, 2024. The Fund has pledged its assets as collateral to secure its obligations under the credit agreement. The Fund retains the risk and rewards of the ownership of the assets pledged to secure its obligations under the credit agreement. As of June 30, 2023, the amount of total outstanding borrowings under the credit agreement was $0.
 
For the six months ended June 30, 2023, the Fund’s activity under the credit facility activity was as follows:
 
         
Weighted
Maximum Amount
Average Daily
Maximum Amount
Interest
Commitment
Average
Available
Borrowings
Outstanding
Expense
Fee
Interest Rate
$15,000,000
$0
$0
$0
$10,487
N/A

Note 10—Subsequent Events
The Fund has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date financial statements were available to be issued.  Based on this evaluation, no adjustments or additional disclosures were deemed to be required to the financial statements as of June 30, 2023.
 




34

THE SWISS HELVETIA FUND, INC.


Information Regarding Approval of Investment Advisory Agreement (Unaudited)


At an in-person meeting held on March 24, 2023, all of the members of the Fund’s Board of Directors who are not “interested persons” (as defined in the Investment Company Act of 1940, as amended) of the Fund (the “Independent Directors”), constituting a majority of the Fund’s Board of Directors, considered and approved a proposal to renew (i) the Investment Advisory Agreement, dated as of April 17, 2014 (the “Advisory Agreement”), between the Fund and Schroder Investment Management North America Inc. (“SIMNA”), and (ii) the Sub-Advisory Agreement, dated as of April 17, 2014, as amended as of November 1, 2015, as of September 19, 2017 and as April 1, 2020 (the “Sub-Advisory Agreement” and, together with the Advisory Agreement, the “Agreements”), between SIMNA and Schroder Investment Management North America Limited (“SIMNA Ltd.” and, together with SIMNA, the “Adviser”).  Prior to the meeting, Fund counsel requested, and the Adviser provided, materials to aid the Directors in their consideration of the proposal.  It was noted that the Directors met over the course of the year with investment advisory personnel from the Adviser and regularly review detailed information regarding the Fund.  In addition, the Board held a meeting via video conference on March 20, 2023 with counsel and representatives of the Adviser to commence review of the materials provided and the relevant legal considerations. In approving the continuation of the Agreements, the Directors considered all factors that they considered relevant, including the specific factors described below.  The Directors did not identify any one factor as all-important or controlling, and each Director attributed different weights to the various factors.
 
The Directors considered various data and information regarding the nature, extent and quality of services provided, including, among other things, information about the background and experience of senior management and investment personnel responsible for managing the Fund. The Directors considered the information provided regarding the portfolio managers and other resources dedicated to the Fund and the investment philosophy and process and disciplined investment approach followed by those individuals in managing the Fund, including the importance of dedicated Switzerland-based portfolio managers.
 
The Directors reviewed the Fund’s investment performance, determining that the Fund’s performance should be evaluated against the achievement of the Fund’s investment objective of seeking long-term capital appreciation through investment primarily in equity and equity-linked securities of Swiss companies. The Directors considered the Fund’s performance against the Swiss Performance Index (the “SPI”) and against a list of non-U.S. funds that invest in Swiss equities in the Morningstar Category “Switzerland Large-Cap Equity (offshore territories)”, which includes two non-U.S. funds advised by the Adviser. Although the performance data for funds included in the list included one-year, two-year, three-year, five-year and 10-year returns ended December 31, 2022, the Directors considered most relevant the total returns for the one-year, three-year, and five year periods ended December 31, 2022 due to the fact that the Adviser commenced management of the Fund effective July 1, 2014.
 
The Directors noted that the Fund’s total return based on net asset value on an absolute basis was -17.97% for the one year period ended December 31, 2022, and that its total return based on share price over that period was -17.62%, both slightly underperforming the 17.16% decrease in the SPI
 


35

THE SWISS HELVETIA FUND, INC.


Information Regarding Approval of Investment Advisory Agreement (Unaudited)
(continued)

for the same period.  The Directors also noted that for the three year and five year periods ending December 31, 2022, the Fund’s annualized total return based on share price underperformed the SPI by 0.23% and 1.96%, respectively, and that the Fund’s annualized total return based on net asset value under underperformed the SPI for those periods by 0.97% and 1.55%, respectively.  The Directors noted that for the quarter ended December 31, 2022, the Fund outperformed the SPI based on a total return net asset value basis by 1.27 and share price basis by 2.17% and that for the two month period ended February 28, 2023, the Fund slightly outperformed the SPI on a total return net asset value basis by 0.15% and slightly underperformed based on share price by 0.42%. The Directors also noted that the Fund generally outperformed the Adviser’s non-U.S. peer funds on a total return net asset value basis for the one-year, three year and five-year periods ended December 31, 2022.  The Directors also observed that, unlike the Fund, the returns of the SPI and the peer funds were not subject to the same regulatory restrictions, including issuer and concentration limits, applicable to the Fund by virtue of the Investment Company Act.
 
The Directors reviewed the information provided by the Adviser and compiled by Broadridge showing a comparison of the Adviser’s fee rate for the Fund, as well as the Fund’s expense ratio, compared to a peer group of U.S. registered closed-end funds selected independently by Broadridge having similar objectives, strategies and asset sizes as the Fund.  The Directors noted that the Fund ranked in the first quintile with respect to the Adviser’s contractual fee, second quintile with respect to the Adviser’s actual fee, fifth quintile with respect to the Fund’s total expenses and fifth quintile with respect to the Fund’s non-management expenses. The Directors considered that in November 2018 the Fund completed a large self-tender offer that reduced the size of the Fund and thereby increased expense ratios for the Fund commencing in 2019. The Directors considered that the peer non-U.S. funds advised by the Adviser had higher management fees compared to the Fund.
 
The Directors considered information regarding the profitability of the Fund’s advisory arrangements to the Adviser.  The Adviser discussed the methodology utilized for determining its profitability.  The Directors determined that the level of profitability did not appear inappropriate or unreasonable at this time.  The Directors noted that the Adviser experienced a decrease in profitability in 2022 compared to 2021 due to a decrease in the dollar amount of assets under management during the year.  During 2022 the Fund had average net assets of $123.7 million whereas during 2021 the Fund had average net assets of $144 million.
 
The Directors considered that the Fund is a closed-end fund and that it was not expected to have meaningful asset growth absent primarily a rights offering or an acquisition. They did not view the potential for realization of economies of scale as the Fund’s assets grow to be a meaningful factor in their deliberations, and that due to the Fund’s significant tender offer completed in November 2018, it does not appear that the Fund will likely experience economies of scale in the near future. The Non-Interested Directors noted, however, that the advisory fee rate schedule under the Advisory Agreement contains multiple breakpoints commencing with assets of U.S. $250 million and above and that these breakpoints would benefit stockholders.
 


36

THE SWISS HELVETIA FUND, INC.


Information Regarding Approval of Investment Advisory Agreement (Unaudited)
(concluded)

The Directors considered information regarding the financial position of each of SIMNA and SIMNA Ltd. and were satisfied that they each have adequate resources to continue to perform the services required under the Agreements.
 
The Directors considered other benefits that the Adviser or its parent could be considered to derive from their relationship with the Fund, including the marketing value of the Fund’s performance in attracting other clients. The Directors determined that these benefits were relatively minor and did not affect their overall assessment of the reasonableness of the relationship.
 
Based on the evaluation of these factors, the Board of Directors, including the Independent Directors, unanimously concluded that the Fund’s advisory fee rate was reasonable in relation to the service rendered by the Adviser and, therefore, approved the continuation of the Agreements.
 



37

THE SWISS HELVETIA FUND, INC.


Additional Information (Unaudited)
 

This report is sent to the stockholders of the Fund for their information. It is not a prospectus, circular or representation intended for use in the purchase or sale of shares of the Fund or of any securities mentioned in this report.
 
Proxy Voting Information
A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities is available, without charge and upon request, by calling (800) 730-2932 and on the SEC’s website at http://www.sec.gov. The Fund’s proxy voting record for the twelve-month period ended June 30 is available, without charge and upon request, by calling (800) 730-2932 and on the SEC’s website at http://www.sec.gov.
 
Availability of Quarterly Portfolio Schedules
The Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Part F of Form N-PORT. The Fund’s Part F of Form N-PORT are available on the SEC’s website at http://www.sec.gov.
 
Code of Ethics
The Board of Directors of the Fund and the Advisor have adopted Codes of Ethics pursuant to Rule 17j-1 under the Act and Rule 204A-1 under the Investment Advisers Act of 1940, as amended the “Codes”). The Codes apply to the personal investing activities of various individuals including directors and officers of the Fund, the Fund’s portfolio managers and designated officers, directors and employees of the Advisor. The provisions of the Codes place restrictions on individuals who are involved in managing the Fund’s portfolio, who help execute the portfolio managers’ decisions or who come into possession of contemporaneous information concerning the investment activities of the Fund.
 
The fundamental principle of the Codes is that the individuals covered by the Codes have a fiduciary responsibility to the Fund and its stockholders. They are, therefore, required at all times to place the interests of the Fund and the stockholders first and to conduct all personal securities transactions in a manner so as to avoid any actual or potential conflict of interest or abuse of their position of trust.
 
Portfolio managers and other individuals, within the Advisor, with knowledge of Fund investment activities are prohibited from purchasing or selling a security during a blackout period of 30 calendar days before and after the date on which the Fund effects a trade in the same or a similar security. They are also prohibited from engaging in short-term trading of Swiss equity or equity-linked securities.
 
Additionally, the Fund’s portfolio managers are prohibited from participating in any initial public offering or private placement of Swiss equity and equity-linked securities and other covered individuals must obtain prior clearance before doing so.
 
The Advisor’s Code provides that any individual subject to such Code and who violates the provisions of the Code is required to reverse the transaction and to turn over any resulting profits to the Fund. The Fund and the Advisor have adopted compliance procedures and have appointed compliance officers to ensure that all covered individuals comply with the Codes.
 


38

THE SWISS HELVETIA FUND, INC.


Additional Information (Unaudited) (concluded)
 

Federal Tax Distribution Information
The Fund designates 100% of its ordinary income dividend distributions for the qualified dividend rate (QDI) as defined in Section 1(h)(11) of the Internal Revenue Code.
 
The amounts may differ from those elsewhere in this report because of difference between tax and financial reporting requirements. For federal income tax purposes, distributions from short-term capital gains are classified as ordinary income.  The Fund designated 0.00% of taxable ordinary income distributions designated as short-term capital gain distributions under Internal Revenue Section 871 (k)(2)(C).
 
The Fund intends to elect to pass through to stockholders the income tax credit for taxes paid to foreign countries. Foreign source income and foreign tax expense per outstanding shares on December 31, 2022, were $0.26 and $0.04 per share, respectively.
 
Foreign Income Information
Pursuant to Section 853 of the Internal Revenue Code, the Fund designates the following amounts as foreign taxes paid for the year ended December 31, 2022. Foreign taxes paid for purposes of Section 853 may be less than actual foreign taxes paid for financial statement purposes.
 
Gross Foreign
Foreign Taxes
Gross Foreign
Foreign Taxes
Shares Outstanding
Source Income
Pass-through
Source Income Per Share
Pass-through Per Share
at 12/31/22
$3,473,999
$489,567
$0.26326651
$0.03710035
13,195,750





39

THE SWISS HELVETIA FUND, INC.


Certain Information Concerning Directors (Unaudited)


The following tables set forth certain information about each person currently serving as a Director of the Fund, including his or her beneficial ownership of Common Stock of the Fund. All information presented in the tables is as of June 30, 2023.
 
 
Position(s)
 
Other Directorships
Name,
with Fund
Principal Occupation(s)
Held By Director
Address1 & Age
(Since)
During At Least The Past Five Years
During At Least The Past Five Years
Class I
Richard Dayan
Director (2018);
President and owner of
Trustee of High Income Securities
 
Member of the
Cactus Trading since 1990
Fund since 2018
Age: 79
Audit Committee (2018);
   
 
Member of the
   
 
Governance/
   
 
Nominating
   
 
Committee (2018)
   
Moritz A. Sell
Director (2017);
Principal, Edison Holdings GmbH;
Trustee of High Income Securities
 
Member and
Senior Advisor, Markston
Fund since 2018; Director of FAX
Age: 55
Chair of the Audit
International LLC until 2019; Director,
(Aberdeen Asia Pacific Income
 
Committee (2017);
Market Strategist and Head of
Fund) and FCO (Aberdeen Global
 
Lead Independent
Proprietary Trading (London Branch),
Income Fund) since 2018; Director of
 
Director (2018)
Landesbank Berlin AG and
IAF (Aberdeen Australia Equity Fund)
   
Landesbank Berlin Holding AG
since 2004; Director of Aberdeen
   
(formerly, Bankgesellschaft Berlin AG)
Greater China Fund until 2018;
   
from 1996 to 2013
Chairman and Director of
     
Aberdeen Singapore Fund
     
until 2018
Class II
Andrew Dakos*
Director
Partner, Bulldog Investors, LLP;
President and Director of Special
 
(2017) and
Partner, Ryan Heritage, LLP;
Opportunities Fund, Inc. since
Age: 57
Chairman (2018)
Principal of the former general partner
2009; Trustee, Crossroads
   
of several private investment
Liquidating Trust (formerly,
   
partnerships in the Bulldog
Crossroads Capital, Inc.) from
   
Investors group of private funds;
2015-2020; President and Trustee of
   
Principal of the managing general
High Income Securities Fund since
   
partner of Bulldog Investors
2018; Director, Brookfield DTLA
   
General Partnership
Fund Office Trust Investor Inc.
     
since 2017

*
Mr. Dakos is considered an “interested person” of the Fund within the meaning of the 1940 Act (and a Class II Interested Director of the Fund) as a result of his position as President and Chief Executive Officer of the Fund.


40

THE SWISS HELVETIA FUND, INC.


Certain Information Concerning Directors (Unaudited) (concluded)


 
Position(s)
 
Other Directorships
Name,
with Fund
Principal Occupation(s)
Held By Director
Address1 & Age
(Since)
During At Least The Past Five Years
During At Least The Past Five Years
Class III
Phillip F. Goldstein
Director (2018);
Partner of Bulldog Investors, LLP
Chairman and Director of The
 
Member and
since 2009; Partner of Ryan
Mexico Equity and Income Fund,
Age: 78
Chair of the
Heritage, LLP; Principal of the former
Inc. since 2000; Chairman,
 
Governance/
general partner of several private
Director and Secretary of Special
 
Nominating
investment partnerships in the
Opportunities Fund, Inc. since
 
Committee (2018)
Bulldog Investors group of private
2009; Chairman, Trustee and Secretary
   
funds since 2009; Principal of the
of High Income Securities Fund since
   
managing general partner of
2018; Director of Brookfield DTLA
   
Bulldog Investors General Partnership
Fund Office Trust Investor Inc.
     
since 2017; MVC Capital, Inc. from
     
2012-2020; Trustee of Crossroads
     
Liquidating Trust (formerly,
     
Crossroads Capital, Inc.) from
     
2016-2020
Gerald Hellerman
Director (2018);
Chief Compliance Officer of
Director of Mexico Equity and
 
Member of the
The Mexico Equity and Income Fund,
Income Fund, Inc. since 2001;
Age: 85
Audit Committee
Inc. from 2001 through March 31,
Special Opportunities Fund, Inc.
 
(2018); Member
2020 and Special Opportunities
since 2009; Fiera Capital Series Trust
 
and Chair of the
Fund, Inc. from 2009 through
since 2017; Trustee of High
 
Pricing Committee
March 31, 2020; Managing Director
Income Securities Fund since 2018;
 
(2018)
of Hellerman Associates (a financial
MVC Capital, Inc. from
   
and corporate consulting firm)
2003-2020; Trustee of Crossroads
   
since 1993 (which terminated
Liquidating Trust (formerly, Crossroads
   
activities as of December 31, 2013)
Capital, Inc.) from 2017-2020



41

THE SWISS HELVETIA FUND, INC.


Certain Information Concerning Officers (Unaudited)


The following table sets forth certain information about each person serving as an Officer of the Fund as of June 30, 2023.
 
Officers2
Name,
Position(s)
Term of Office and
Principal Occupation(s)
Address1 & Age
with Fund
Length of Time Served
During At Least The Past Five Years
Andrew Dakos
President and
President and Chief
Partner, Bulldog Investors, LLP;
 
Chief Executive
Executive Officer since 2019;
Partner, Ryan Heritage, LLP;
Age: 57
Officer; Director
Chairman since 2018;
Principal of the former general
 
and Chairman.
Director since 2017
partner of several private
     
investment partnerships in the
     
Bulldog Investors group of private
     
funds; Principal of the managing
     
general partner of Bulldog
     
Investors General Partnership
Thomas Antonucci
Chief Financial
Since 2019
Director of Operations,
 
Officer
 
Bulldog Investors, LLP;
Age: 54
   
Chief Financial Officer
     
and Treasurer of Special
     
Opportunities Fund; Treasurer
     
of High Income Securities Fund
Stephanie Darling
Chief Compliance
Since 2019
General Counsel and Chief
 
Officer
 
Compliance Officer of Bulldog
Age: 53
   
Investors, LLP; Chief Compliance
     
Officer of Ryan Heritage, LLP,
     
High Income Securities
     
Fund, Special Opportunities Fund,
     
Inc., and Mexico Equity and
     
Income Fund, Inc.; Principal of The
     
Law Office of Stephanie Darling;
     
Editor-in-Chief of The
     
Investment Lawyer
Rajeev Das
Secretary
Since 2019
Head of Trading, Bulldog
     
Investors, LLP
Age: 54
     

1
The address for each Director and Executive Officer is c/o The Swiss Helvetia Fund, Inc., 615 East Michigan Street, Milwaukee, WI 53202.
2
Each Executive Officer serves on a year-to-year basis for an indefinite term, until his or her successor is elected and qualified.



42

THE SWISS HELVETIA FUND, INC.


Automatic Dividend Reinvestment Plan (Unaudited)


Terms and Conditions
Pursuant to this Automatic Dividend Reinvestment Plan (the “Plan”) of The Swiss Helvetia Fund, Inc. (the “Fund”), unless a holder (each, a “Stockholder”) of the Fund’s shares of common stock (the “Common Shares”) otherwise elects, all income dividends, capital gain distributions and returns of capital, if any (collectively referred to herein as “dividends”), on such Stockholder’s Common Shares will be automatically reinvested by Equiniti Trust Company, LLC, as agent for Stockholders in administering the Plan (the “Plan Administrator”), in additional Common Shares of the Fund. Stockholders who elect not to participate in the Plan will receive all dividends payable in cash directly to the Stockholder of record (or, if the Common Shares are held in street or other nominee name, then to such nominee) by Equiniti Trust Company, LLC, as the Dividend Disbursing Agent. Stockholders may elect not to participate in the Plan and to receive all dividends in cash by contacting the Plan Administrator. Enrollment, purchase or sales of shares and other transactions or services offered by the Plan can be directed to the Plan Administrator through the following:
 
Telephone
Telephone the Plan Administrator: 1-888-556-0425.
 
In Writing
You may also write to the Plan Administrator at the following address: Equiniti Trust Company, LLC, PO Box 922, Wall Street Station, New York, NY 10269-0560. Be sure to include your name, address, daytime phone number, social security or tax I.D. number and a reference to The Swiss Helvetia Fund, Inc. on all correspondence.
 
Participation in the Plan is completely voluntary and may be terminated at any time without penalty by providing notice in writing to the Plan Administrator at least 3 business days prior to any dividend payment date for that dividend to be payable in cash. A request for termination that is received less than 3 business days prior to any dividend payment date will be processed by the Plan Administrator, but you will have that dividend reinvested in additional Common Shares. However, all subsequent dividends will be payable in cash unless and until you resume participation in the Plan. To resume participation in the Plan, your request to enroll in the Plan must be received by the record date for that dividend distribution. If received after the record date, your participation in the Plan will begin with the next dividend declaration.
 
Whenever the Fund declares a dividend, payable either in Common Shares or in cash, participants in the Plan will receive a number of Common Shares determined in accordance with the following provisions and non-participants in the Plan will receive cash. The Common Shares will be acquired by the Plan Administrator for the participants’ accounts, depending upon the circumstances described below, either: (i) through the receipt of additional unissued but authorized Common Shares from the Fund (“newly issued Common Shares”) or (ii) by purchase of outstanding Common Shares on the open market (“open-market purchases”) on the New York Stock Exchange, the primary national securities exchange on which the Common Shares are traded, or elsewhere.
 


43

THE SWISS HELVETIA FUND, INC.


Automatic Dividend Reinvestment Plan (Unaudited) (continued)


If, on the payment date for any dividend, the net asset value (“NAV”) per Common Share is equal to or less than the market price per Common Share (plus estimated brokerage trading fees) (such condition being referred to herein as “market premium”), the Plan Administrator will invest the dividend amount in newly issued Common Shares on behalf of the participants. The number of newly issued Common Shares to be credited to each participant’s account will be determined by dividing the dollar amount of the dividend by the NAV per Common Share on the date the Common Shares are issued, provided that, if the NAV per Common Share is less than or equal to 95% of the then current market price per Common Share on the date of issuance, the dollar amount of the dividend will be divided by 95% of the market price on the date of issuance for purposes of determining the number of shares issuable under the Plan.
 
If, on the payment date for any dividend, the NAV per Common Share is greater than the market price of the Common Shares (plus estimated brokerage trading fees) (such condition being referred to herein as “market discount”), the Plan Administrator will invest the dividend amount in Common Shares acquired on behalf of the participants in open-market purchases.
 
In the event of a market discount on the payment date for any dividend, the Plan Administrator will have until the last business day before the next date on which the Common Shares trade on an “ex-dividend” basis or in no event more than 30 days after the record date for such dividend, whichever is sooner (the “last purchase date”), to invest the dividend amount in Common Shares acquired in open-market purchases. If, before the Plan Administrator has completed its open-market purchases, the market price of a Common Share exceeds the NAV per Common Share, the average per Common Share purchase price paid by the Plan Administrator may exceed the NAV of the Common Shares, resulting in the acquisition of fewer Common Shares than if the dividend had been paid in newly issued Common Shares on the dividend payment date. Because of the foregoing difficulty with respect to open-market purchases, if the Plan Administrator is unable to invest the full dividend amount in open-market purchases during the purchase period or if the market discount shifts to a market premium during the purchase period, the Plan Administrator may cease making open-market purchases and may invest the uninvested portion of the dividend amount in newly issued Common Shares at the NAV per Common Share at the close of business on the last purchase date provided that, if the NAV is less than or equal to 95% of the then current market price per Common Share, the dollar amount of the dividend will be divided by 95% of the market price on the date of issuance for purposes of determining the number of Common Shares issuable under the Plan.
 
The Plan Administrator maintains all registered Stockholders’ accounts in the Plan and furnishes written confirmation of all transactions in the accounts, including information needed by Stockholders for tax records. Common Shares in the account of each Plan participant generally will be held by the Plan Administrator in non-certificated form
 


44

THE SWISS HELVETIA FUND, INC.


Automatic Dividend Reinvestment Plan (Unaudited) (continued)


in the name of the Plan participant, although the Plan Administrator will issue certificates for whole Common Shares upon your request. Certificates for fractional Common Shares will not be issued.
 
In the case of Stockholders such as banks, brokers or nominees that hold Common Shares for others who are the beneficial owners, the Plan Administrator will administer the Plan on the basis of the number of Common Shares certified from time to time by the record Stockholder and held for the account of beneficial owners who participate in the Plan.
 
There will be no brokerage charges with respect to Common Shares issued directly by the Fund as a result of dividends payable either in Common Shares or in cash. However, each participant will pay a pro rata share of brokerage trading fees incurred with respect to the Plan Administrator’s open-market purchases of Common Shares in connection with the reinvestment of dividends under the Plan.
 
Participants in the Plan may sell any or all of their Common Shares in their Plan accounts by contacting the Plan Administrator. The Plan Administrator currently charges $15.00 for the transaction, plus $0.10 per Common Share for this service. Participants also may withdraw their Common Shares from their Plan accounts and sell those Common Shares through their broker.
 
Neither the Fund nor the Plan Administrator will provide any advice, make any recommendations, or offer any opinion with respect to whether or not you should purchase or sell your Common Shares or otherwise participate in the Plan. You must make independent investment decisions based on your own judgment and research. The Common Shares held in Plan accounts are not subject to protection under the Securities Investor Protection Act of 1970.
 
Neither the Fund nor the Plan Administrator will be liable for any good faith act or for any good faith omission to act, including, without limitation, any claim or liability arising out of failure to terminate a participant’s account upon the participant’s death, the prices at which Common Shares are purchased or sold for a participant’s account, the times when purchases or sales of Common Shares are made, or fluctuations in the market value of Common Shares. However, nothing contained in this provision affects a Stockholder’s right to bring a cause of action based on alleged violations of the federal securities laws.
 
Voting
Each Stockholder proxy will include those Common Shares purchased or received pursuant to the Plan. The Plan Administrator will forward all proxy solicitation materials to participants and vote proxies for Common Shares held pursuant to the Plan in accordance with the instructions of the participants.
 
Taxation
The automatic reinvestment of dividends will not relieve participants of any federal, state or local income tax that may be payable (or required to be withheld) on such dividends.
 


45

THE SWISS HELVETIA FUND, INC.


Automatic Dividend Reinvestment Plan (Unaudited) (concluded)


Amendments to Plan
The Fund reserves the right to suspend, amend or terminate the Plan at any time. All Stockholders of record, both participants and non-participants in the Plan, will be notified of any suspension, termination or significant amendment of the Plan. If the Plan is terminated, Common Shares held in the participants’ accounts will be distributed to the participants. Any change in the source of purchase of Common Shares under the Plan from open market purchases or direct issuance by the Plan Administrator does not constitute an amendment to the Plan.
 



46

THE SWISS HELVETIA FUND, INC.


Directors and Officers
Andrew Dakos
Gerald Hellerman1,4
Chairman, President and
Director
Chief Executive Officer
Thomas Antonucci
Richard Dayan1,5
Chief Financial Officer
Director
Stephanie Darling
Phillip Goldstein2
Chief Compliance Officer
Director
Rajeev Das
Moritz Sell3,6
Secretary
Director
 
1
Audit Committee Member
4
Pricing Committee Chair
2
Governance Nominating
5
Governance Committee
 
Committee Chair
 
Member
3
Audit Committee Chair
6
Lead Independent Director


Investment Adviser
Schroder Investment Management North America Inc.
7 Bryant Park
New York, NY 10018-3706
(800) 730-2932
 
Investment Sub-adviser
Schroder Investment Management North America Ltd.
1 London Wall Place
London, EC2Y, United Kingdom
 
Administrator
U.S. Bank Global Fund Services
 
Custodian
U.S. Bank, N.A.
 
Transfer Agent
Equiniti Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(888) 556-0425
 
Legal Counsel
Sullivan & Cromwell LLP
 
Independent Registered Public Accounting Firm
Tait, Weller & Baker LLP
 
The Investment Adviser
The Swiss Helvetia Fund, Inc. (the “Fund”) is managed by Schroder Investment Management North America Inc. (“SIMNA Inc.”).
 
SIMNA Inc. is an investment adviser registered with the U.S. Securities & Exchange Commission (the “SEC”). It provides asset management products and services to a broad range of clients including Schroder Series Trust and Schroder Global Series Trust, investment companies registered with the SEC. SIMNA Inc. is part of a global asset management firm with approximately $923.1 billion in assets under management and administration as of June 30, 2023.
 
Executive Offices
The Swiss Helvetia Fund, Inc.
615 East Michigan Street
Milwaukee, WI 53202
(800) 730-2932
 
For inquiries and reports:
(800) 730-2932
email: swzintermediary@schroders.com
 
Website Address
www.swzfund.com
 
The Fund
The Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
 
The Fund is listed on the New York Stock Exchange under the symbol “SWZ”.
 
Net Asset Value is calculated daily by 6:15 P.M. (Eastern Time). The most recent calculation is available by accessing the Fund’s website www.swzfund.com. Net Asset Value is also published weekly in Barron’s, the Monday edition of The Wall Street Journal and the Sunday edition of The New York Times.
 
47


(b) Not applicable for this Registrant.

Item 2. Code of Ethics.

Not applicable for semi-annual reports.

Item 3. Audit Committee Financial Expert.

Not applicable for semi-annual reports.

Item 4. Principal Accountant Fees and Services.

Not applicable for semi-annual reports.

Item 5. Audit Committee of Listed Registrants.

Not applicable for semi-annual reports.

Item 6. Investments.

Schedule of Investments is included as part of the report to shareholders filed under item 1 of the Form.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable for semi-annual reports.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable for semi-annual reports.

Item 9. Purchases of Equity Securities by Closed‑End Management Investment Company and Affiliated Purchasers.

The following purchases were made by or on behalf of the registrant or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended, of shares of the registrant’s equity securities that are registered by the Registrant pursuant to Section 12 of the Exchange Act made in the period covered by this report.

Period
(a)
Total Number of
Shares (or Units)
Purchased
(b)
Average Price Paid
per Share (or Unit)
(c)
Total Number of
Shares (or Units)
Purchased as Part
of Publicly
Announced Plans
or Programs
(d)
Maximum Number
(or Approximate
Dollar Value) of
Shares (or Units)
that May Yet Be
Purchased Under
the Plans or
Programs
1/1/23 – 1/31/23
N/A
N/A
N/A
N/A
2/1/23 – 2/28/23
4,510
7.80
N/A
N/A
3/1/23 – 3/31/23
8,168
7.71
N/A
N/A
4/1/23 – 4/30/23
177,533
8.24
N/A
N/A
5/1/23 – 5/31/23
12,649
8.34
N/A
N/A
6/1/23 – 6/30/23
2,185
8.07
N/A
N/A
Total
205,045
8.06
N/A
N/A

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of trustees.

Item 11. Controls and Procedures.

(a)
The Registrant’s President and Chief Executive Officer and Chief Financial Officer have reviewed the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d‑15(b) under the Securities Exchange Act of 1934.  Based on their review, such officers have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant and by the Registrant’s service provider.

(b)
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

The registrant did not engage in securities lending activities during the fiscal period reported on this Form N-CSR.

Item 13. Exhibits.

(a)
(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit. Not applicable.


(3) Any written solicitation to purchase securities under Rule 23c‑1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons.  None.

(4) Change in the registrant’s independent public accountant.  There was no change in the registrant’s independent public accountant for the period covered by this report.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


(Registrant)       The Swiss Helvetia Fund, Inc. 

By (Signature and Title)      /s/ Andrew Dakos
Andrew Dakos, President and Chief Executive Officer

Date    8/29/2023



Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)      /s/ Andrew Dakos
Andrew Dakos, President and Chief Executive Officer

Date    8/29/2023


By (Signature and Title)      /s/ Thomas Antonucci
Thomas Antonucci, Chief Financial Officer

Date    8/29/2023










Exhibit 99.CERT
 
CERTIFICATIONS

I, Andrew Dakos, certify that:

 
1.
 
I have reviewed this report on Form N-CSR of The Swiss Helvetia Fund, Inc.;
 
2.
 
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
 
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4.
 
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a)
 
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)
 
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)
 
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d)
 
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
 
The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)
 
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
(b)
 
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:   8/29/2023
 
/s/Andrew Dakos
Andrew Dakos
President and Chief Executive Officer


CERTIFICATIONS

I, Thomas Antonucci, certify that:

 
1.
 
I have reviewed this report on Form N-CSR of The Swiss Helvetia Fund, Inc.;
 
2.
 
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
 
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4.
 
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a)
 
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)
 
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)
 
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d)
 
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
 
The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)
 
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
(b)
 
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:   8/29/2023
 
/s/Thomas Antonucci
Thomas Antonucci
Chief Financial Officer



Exhibit 99.906CERT
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of The Swiss Helvetia Fund, Inc., does hereby certify, to such officer’s knowledge, that the report on Form N-CSR of The Swiss Helvetia Fund, Inc. for the period ended June 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of The Swiss Helvetia Fund, Inc. for the stated period.


/s/Andrew Dakos
Andrew Dakos
President and Chief Executive Officer,
The Swiss Helvetia Fund, Inc.
 
/s/Thomas Antonucci
Thomas Antonucci
Chief Financial Officer,
The Swiss Helvetia Fund, Inc.
 
Dated:   8/29/2023
 


This statement accompanies this report on Form N-CSR pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed as filed by The Swiss Helvetia Fund for purposes of Section 18 of the Securities Exchange Act of 1934.




Exhibit 99.19a-033123
For immediate release

 
THE SWISS HELVETIA FUND, INC.
Notification of Sources of Distribution
Pursuant to Section 19(a) of the Investment Company Act of 1940

Important Information Regarding Quarterly Distribution

March 31, 2023 – As previously announced, on March 31, 2023, The Swiss Helvetia Fund, Inc. (NYSE:SWZ),  a non-diversified registered closed-end investment company (the "Fund"), paid a quarterly distribution of $0.12285 per share of the Fund’s common stock to all stockholders of record as of March 22, 2023, pursuant to the Fund’s managed distribution plan (the “Plan”).

As a general matter, the amount of the Fund’s distributable income depends on the aggregate gains and losses realized by the Fund during the Fund’s entire fiscal year.  Distributions may consist of net investment income, capital gains and return of capital but the character of these distributions cannot be determined until after the end of the Fund’s fiscal year.  However, under the Investment Company Act of 1940, as amended, and the terms of the Plan, the Fund may be required to indicate the source of each distribution to its stockholders.  The following table sets forth the estimated sources of the current distribution and of the cumulative distributions paid during the 2023 fiscal year from the sources indicated in the table. All amounts in the following table are expressed on a per common share basis and as a percentage of the distribution amount.

DISTRIBUTION ESTIMATES 

  Current Distribution 
                      2023 Fiscal Year*
         
 
Per Share
Amount
% of
Current
Distribution
Per Share
Amount
% of the 2023
Distributions
Net Investment Income
$0.02840
  23.12%
$0.02840
  23.12%
Net Realized Short-Term Capital Gains
$0.00000
    0.00%
$0.00000
    0.00%
Net Realized Long-Term Capital Gains
$0.00000
    0.00%
$0.00000
    0.00%
Return of Capital (or other Capital Source)
$0.09445
  76.88%
$0.09445
  76.88%
TOTAL
$0.12285
100.00%
$0.12285
100.00%
 
*  The Fund's 2022 fiscal year began on January 1, 2023 and ends December 31, 2023.
 

You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Plan. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the entirety of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of estimated distributions may be subject to additional adjustments.

THE FUND WILL SEND STOCKHOLDERS A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES.


-1-



Fund Performance and Distribution Information
 
Presented below are return figures, based on the change in the Fund's net asset value ("NAV") per share, compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last day of the month prior to the Fund’s most recent distribution record date.

Fiscal Year-to-Date (January 1, 2023 to February 28, 2023)
Annualized Distribution Rate as a % of NAV*
5.42%
 
Cumulative Distribution Rate on NAV*
0.00%
 
Cumulative Total Return on NAV**
2.95%
 
Average Annual Total Return (in relation to NAV) for
the five-year period ended February 28, 2023***
 
5.50%
 
 
*
Based on the Fund's NAV as of February 28, 2023.
 
**
Cumulative fiscal year-to-date return is based on the change in NAV including distributions paid and assuming reinvestment of these distributions for the period January 1, 2023 through February 28, 2023.
 
***
Average annual total return is based on change in NAV including distributions paid and assuming reinvestment of these distributions and is through the last business day of the month prior to the month of the current distribution record date.
 

The payment of distributions in accordance with the Plan may result in a decrease in the Fund's net assets.  A decrease in the Fund's net assets may cause an increase in the Fund's annual operating expense ratio and a decrease in the Fund's market price per share to the extent the market price correlates closely to the Fund's NAV per share.  The Plan also may negatively affect the Fund's investment activities to the extent that the Fund is required to hold larger cash positions than it typically would hold or to the extent that the Fund must liquidate securities that it would not have sold, for the purpose of paying the distribution.

The current distribution amount of $0.12285 per share of the Fund's common stock equates to an annualized distribution rate of 6.00% based on the Fund’s NAV per share as of October 31, 2022.  The annualized rate is expected to change over time as the Fund's NAV varies. The Board will review periodically the terms of the Plan, including at least annually, to determine whether to adjust the amount or the calculation of the distribution rate, which may be affected by numerous factors, including changes in realized and projected market returns, Fund performance and other factors.  The Board may amend the terms of the Plan or terminate the Plan at any time without prior notice to the Fund's stockholders.  The amendment or termination of the Plan could have an adverse effect on the market price of the Fund's shares of common stock.

 
For additional information, please contact the Fund at (800) 730-2932.






-2-




Exhibit 99.19a-063023
For immediate release

 
THE SWISS HELVETIA FUND, INC.
Notification of Sources of Distribution
Pursuant to Section 19(a) of the Investment Company Act of 1940

Important Information Regarding Your Quarterly Distribution

June 30, 2023 – As previously announced, on June 30, 2023, The Swiss Helvetia Fund, Inc. (the "Fund") paid a quarterly distribution of $0.12285 per share of the Fund’s common stock to all stockholders of record as of June 21, 2023, pursuant to the Fund’s managed distribution plan (the “Plan”).

As a general matter, the amount of the Fund’s distributable income depends on the aggregate gains and losses realized by the Fund during the Fund’s entire fiscal year.  Distributions may consist of net investment income, capital gains and return of capital but the character of these distributions cannot be determined until after the end of the Fund’s fiscal year.  However, under the Investment Company Act of 1940, as amended, and the terms of the Plan, the Fund may be required to indicate the source of each distribution to its stockholders.  The following table sets forth the estimated sources of the current distribution and of the cumulative distributions paid during the 2023 fiscal year from the sources indicated in the table. All amounts in the following table are expressed on a per common share basis and as a percentage of the distribution amount.

DISTRIBUTION ESTIMATES 
                     
  Current Distribution  2023 Fiscal Year* 
         
 
Per Share
Amount
% of
Current
Distribution
Per Share
Amount
% of the 2023
Distributions
Net Investment Income
$0.10991
  89.47%
$0.13875
  56.47%
Net Realized Short-Term Capital Gains
$0.00132
    1.07%
$0.00000
    0.00%
Net Realized Long-Term Capital Gains
$0.01162
    9.46%
$0.00000
    2.77%
Return of Capital (or other Capital Source)
$0.00000
    0.00%
$0.10015
  40.76%
TOTAL
$0.12285
100.00%
$0.24570
100.00%
 
*  The Fund's 2022 fiscal year began on January 1, 2023 and ends December 31, 2023.
 

You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Plan. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the entirety of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of estimated distributions may be subject to additional adjustments.

THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES.


-1-



Fund Performance and Distribution Information
 
Presented below are return figures, based on the change in the Fund's net asset value ("NAV") per share, compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last day of the month prior to the Fund’s most recent distribution record date.

Fiscal Year-to-Date (January 1, 2023 to May 31, 2023)
Annualized Distribution Rate as a % of NAV*
5.16%
 
Cumulative Distribution Rate on NAV*
1.29%
 
Cumulative Total Return on NAV**
9.66%
 
Average Annual Total Return (in relation to NAV) for
the five-year period ended May 31, 2023***
 
7.85%
 
 
*
Based on the Fund's NAV as of May 31, 2023.
 
**
Cumulative fiscal year-to-date return is based on the change in NAV including distributions paid and assuming reinvestment of these distributions for the period January 1, 2023 through May 31, 2023.
 
***
Average annual total return is based on change in NAV including distributions paid and assuming reinvestment of these distributions and is through the last business day of the month prior to the month of the current distribution record date.
 

The payment of distributions in accordance with the Plan may result in a decrease in the Fund's net assets.  A decrease in the Fund's net assets may cause an increase in the Fund's annual operating expense ratio and a decrease in the Fund's market price per share to the extent the market price correlates closely to the Fund's NAV per share.  The Plan also may negatively affect the Fund's investment activities to the extent that the Fund is required to hold larger cash positions than it typically would hold or to the extent that the Fund must liquidate securities that it would not have sold, for the purpose of paying the distribution.

The current distribution amount of $0.12285 per share of the Fund's common stock equates to an annualized distribution rate of 6.00% based on the Fund’s NAV per share as of October 31, 2022.  The annualized rate is expected to change over time as the Fund's NAV varies. The Board will review periodically the terms of the Plan, including at least annually, to determine whether to adjust the amount or the calculation of the distribution rate, which may be affected by numerous factors, including changes in realized and projected market returns, Fund performance and other factors.  The Board may amend the terms of the Plan or terminate the Plan at any time without prior notice to the Fund's stockholders.  The amendment or termination of the Plan could have an adverse effect on the market price of the Fund's shares of common stock.

For additional information, please contact the Fund at (800) 730-2932.






-2-

v3.23.2
N-2 - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cover [Abstract]              
Entity Central Index Key   0000813623          
Amendment Flag   false          
Document Type   N-CSRS          
Entity Registrant Name   Swiss Helvetia Fund, Inc.          
Capital Stock, Long-Term Debt, and Other Securities [Abstract]              
Capital Stock [Table Text Block]  
Note 4—Capital Share Transactions
The Fund is authorized to issue up to 50 million shares of capital stock. Transactions in capital shares were as follows:
 
   
For the Period Ended
   
For the Year Ended
 
   
June 30, 2023
   
December 31, 2022
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Dividends Reinvested
   
   
$
     
   
$
 
Repurchased through Stock Repurchase Program (Note 6)
   
(205,045
)
   
(1,687,598
)
   
(16,504
)
   
(120,928
)
Repurchased from Tender Offer (Note 7)
   
     
     
     
 
Net Increase/(Decrease)
   
(205,045
)
 
$
(1,687,598
)
   
(16,504
)
 
$
(120,928
)
         
Document Period End Date   Jun. 30, 2023          
Common Shares [Member]              
General Description of Registrant [Abstract]              
Share Price $ 8.22 $ 8.22 $ 7.56 $ 9.94 $ 8.94 $ 8.41 $ 6.90
NAV Per Share $ 9.70 $ 9.70 $ 8.80 $ 11.50 $ 10.45 $ 9.71 $ 7.96
Capital Stock, Long-Term Debt, and Other Securities [Abstract]              
Outstanding Security, Authorized [Shares] 50,000,000            
Outstanding Security, Not Held [Shares] 12,990,705            

Swiss Helvetia (NYSE:SWZ)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Swiss Helvetia Charts.
Swiss Helvetia (NYSE:SWZ)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Swiss Helvetia Charts.